Page last updated: 2024-12-04

phenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID996
CHEMBL ID14060
CHEBI ID15882
CHEBI ID33853
MeSH IDM0029379

Synonyms (286)

Synonym
phenol, dimer
BIDD:ER0293
bdbm26187
chembl14060 ,
73607-76-8
phenol, labeled with carbon-14
(14c)phenol
acide phenique
karbolsaeure
CHEBI:15882 ,
carbolsaeure
carbolic acid, liquid
phenyl hydrate
phenyl alcohol
baker's p & s liquid & ointment
phenole
izal
wln: qr
fenolo
fenol(dutch, polish)
phenol, synthetic
oxybenzene
phenol (liquid)
phenol, liquid
synthetic phenol
phenylic alcohol
nsc36808
phoh
nci-c50124
monophenol
baker's p and s liquid and ointment
phenol, liquefied
monohydroxybenzene
nsc-36808
acide carbolique
phenyl hydroxide
paoscle
phenol, pure
liquefied phenol (jp17)
phenol (jp17/usp)
phenol for disinfection (jp17)
phenol for disinfection (tn)
D00033
phenol (tn)
paoscle (tn)
liquefied phenol (tn)
phenol, molten
campho-phenique cold sore gel
fema no. 3223
benzene, hydroxy-
ai3-01814
ccris 504
rcra waste no. u188
un 2312 (molten)
fenolo [italian]
monohydroxy benzene
carbolsaure [german]
rcra waste number u188
phenol [jan]
fenol [dutch, polish]
un2821
phenol alcohol
campho-phenique gel
phenol, solid
un1671
einecs 203-632-7
campho-phenique liquid
un 1671 (solid)
acide carbolique [french]
phenic
epa pesticide chemical code 064001
phenole [german]
nsc 36808
hsdb 113
caswell no. 649
liquid phenol
baker's p and s
un2312
phenosmolin
fenosmoline
fenosmolin
phenol, puriss. p.a., acs reagent, reag. ph. eur., 99.0-100.5%
inchi=1/c6h6o/c7-6-4-2-1-3-5-6/h1-5,7
NCGC00091454-01
C00146
phenylic acid
benzenol
phenylalcohol
carbolic acid
hydroxybenzene
108-95-2
PHENOL ,
phenic acid
phenol, bioxtra, >=99.5% (gc)
phenol, >=99%
liquified phenol, meets usp testing specifications, >=89.0%
phenol, for molecular biology
DB03255
1LI2
1AI7
phenol, contains hypophosphorous as stabilizer, loose crystals, acs reagent, >=99.0%
phenol, unstabilized, reagentplus(r), >=99%
phenol, unstabilized, purified by redistillation, >=99%
NCGC00091454-02
NCGC00091454-03
65996-83-0
carbol
phenol, bioultra, for molecular biology, te-saturated, ~73% (t)
phenol, puriss., meets analytical specification of ph. eur., bp, usp, 99.5-100.5% (gc)
phenol, puriss., meets analytical specification of ph. eur., bp, usp, >=99.5% (gc), crystalline (detached)
P1610
BMSE000290
phenol, solid [un1671] [poison]
phenol, molten [un2312] [poison]
liquified phenol
MLS001065591
2-allphenol
carbolicum acidum
smr000568492
phenol,liquified
phenol, liquified
liquefied phenol
ent-1814
BMSE010026
FT-0693833
AKOS000119025
NCGC00091454-04
NCGC00091454-05
NCGC00091454-06
fenol
phenol [usp:jan]
339ncg44tv ,
unii-339ncg44tv
carbolsaure
ec 203-632-7
dtxcid501124
tox21_300042
dtxsid5021124 ,
NCGC00259188-01
cas-108-95-2
NCGC00254019-01
tox21_113463
tox21_201639
27073-41-2
phenol, sulfurated
61788-41-8
63496-48-0
AM802906
FT-0673707
FT-0645154
4I7L
phenol-3,5-d2
phenol, 80% in ethanol
BP-30160
phenol [ep monograph]
methyl salicylate impurity b [ep]
hexylresorcinol impurity a [ep impurity]
phenol [ii]
phenol [usp-rs]
phenol [usp monograph]
phenol,liquified [vandf]
salicylic acid impurity c [ep impurity]
phenol [vandf]
carbolicum acidum [hpus]
phenol [mi]
phenol [fhfi]
phenol [inci]
metacresol impurity a [ep impurity]
phenol [hsdb]
phenol [who-dd]
phenol [iarc]
phenol [mart.]
NCGC00091454-07
3F39
tox21_113463_1
c6h5oh
hydroxy benzene
un 2312
un 1671
na 2821
un 2821
phenic alcohol
J-610001
mfcd00002143
phenol, ultrapure
F1908-0106
phenol, bioultra, for molecular biology, >=99.5% (gc)
phenol, for molecular biology, ~90% (t), liquid
phenol, detached crystals
pandy's reagent
phenol, jis special grade, >=99.0%
phenol, united states pharmacopeia (usp) reference standard
phenol, saj first grade, >=98.0%
phenol, >=99.0%
phenol, pestanal(r), analytical standard
phenol, acs reagent
phenol, ar, >=99.5%
phenol, natural, 97%, fg
phenol, lr, >=99%
phenol, p.a., acs reagent, 99.5-100.5%
phenol 100 microg/ml in methanol
phenol 10 microg/ml in methanol
hydroxy-benzene
cuticura pain relieving ointment
benzophenol
phenol synthetic
phenol liquid
phenol molten
carbolic acid liquid
cepastat lozenges
liquified phenol (contains 7-10 % water)
phenol acs grade
phenol (cga 73330)
CHEBI:33853
arenols
phen-2,4,6-d3-ol-d
phenol,(s)
phenol 5000 microg/ml in methanol
Q130336
phenol;phenol [jan];phenol, pure;phenol phenol [jan] phenol, pure
STL194294
17442-59-0
2-phenyl alcohol
phenol, glass distilled under argon
EN300-19432
P2771
phenol 1000 microg/ml in dichloromethane
phenol (usp monograph)
phenol (iarc)
topcarecherry flavor
usepa/opp pesticide code: 064001
vortex moisturizer oral
publix sore throat fast relief oral anesthetic
heb sore throatcherry flavor
fortinia id
sore throat relief
drx choice sore throatmenthol flavor
sore throat reliefmenthol
wild horse 777 oral
phenol 0.6% anesthetic oral rinse
hexylresorcinol impurity a (ep impurity)
phenol (usp-rs)
topcare sore throatmenthol flavor
a13-01814
sore throat cherry
pain relievingpetro carbo
good neighbor sore throatcherry flavor
sore throatreadyincase
nice sore throat cherry
chloraseptic sore throat
walgreens sore throatcherry flavor
topcare sore throat
eos medicated pain relieving lip balm
phylorinol
meijer sore throat
rugbycherry flavor
cepastatextra strength
walgreens sore throat
ulcerease
karbolsaure
abc sore throatmenthol flavor
cvs health sore throat fast relief oral anesthetic
phenol (mart.)
good neighbor sore throat
acidum carbolicum
chloraseptic sore throat cherry
sore throat spray
phenol (ii)
heb sore throatmenthol flavor
phenol (usp:jan)
sore throat reliefcherry
metacresol impurity a (ep impurity)
abc sore throat
nice sore throat spearmint
sore throatmenthol
sore throatcherry
drx choice sore throat
phenol (ep monograph)
publix sore throat
heb sore throat
chloraseptic sore throat citrus
castellani paint 1.5%
publix sore throatmenthol flavor
fungus fighte
sore throat reliefcherry flavor
Z104473830

Research Excerpts

Overview

Phenol is an attractant at low, micromolar concentrations and a repellent at high, millimolar concentrations. Phenol is a serious pollutant to the environment, therefore, it is urgent to find a rapid and effective method for its removal.

ExcerptReferenceRelevance
"Phenol is a common pollutant found in wastewater, and its allowable discharge limit is 0.5 parts-per-million (ppm). "( Quantitative detection of phenol in wastewater using square wave voltammetry with pre-concentration.
Kun-Lin, Y; Yi, Z, 2021
)
2.36
"Phenol is an attractant at low, micromolar concentrations and a repellent at high, millimolar concentrations."( Characterization of Opposing Responses to Phenol by Bacillus subtilis Chemoreceptors.
Bodhankar, GA; Foust, ZL; Ordal, GW; Rao, CV; Tohidifar, P, 2022
)
1.71
"Phenol is a hazardous organic solvent to living organisms, even in its small amounts. "( Phenol biodegradation by immobilized Rhodococcus qingshengii isolated from coking effluent on Na-alginate and magnetic chitosan-alginate nanocomposite.
Darvishi, F; Mahdavinia, GR; Mortazavi, SS; Shahabivand, S, 2022
)
3.61
"Phenol is an important chemical material that is widely used in industry. "( Recent Advances in the Heterogeneous Photocatalytic Hydroxylation of Benzene to Phenol.
Han, W; Ji, Y; Shi, J; Xiang, W, 2022
)
2.39
"Phenol is a serious pollutant to the environment, therefore, it is urgent to find a rapid and effective method for its removal. "( Sustained degradation of phenol under extreme conditions by polyurethane-based Bacillus sp. ZWB3.
Liang, J; Liang, M; Zhang, J; Zheng, Y; Zhou, X, 2023
)
2.66
"Phenol is a common chemical posing serious environmental hazard."( Biodegradation of phenol in saline or hypersaline environments by bacteria: A review.
Duan, W; Li, H; Lin, Y; Meng, F; Zheng, Y, 2019
)
1.57
"Phenol is a toxic environmental pollutant and a typical lignin-derived phenolic inhibitor."( Engineered bacterial biofloc formation enhancing phenol removal and cell tolerance.
Bai, F; Jia, X; Li, J; Wu, B; Xia, J; Xiao, Y; Yao, R; Zhang, S; Zhao, X, 2020
)
1.53
"Phenolic compounds are a class of degradation products of lignin."( Dearomatization-Rearomatization Strategy for Synthesizing Carbazoles with 2,2'-Biphenols and Ammonia by Dual C(Ar)-OH Bond Cleavages.
Cao, D; Li, CJ; Yu, J; Zeng, H, 2020
)
1.51
"Phenol is a hazardous chemical known to be widely distributed in aquatic environments. "( Acinetobacter sp. DW-1 immobilized on polyhedron hollow polypropylene balls and analysis of transcriptome and proteome of the bacterium during phenol biodegradation process.
Gu, Q; Guo, W; Sun, M; Wu, H; Wu, Q; Zhang, J, 2017
)
2.1
"Phenol is a common water pollutant because of its broad industrial applications. "( Construction of an Escherichia coli strain to degrade phenol completely with two modified metabolic modules.
Fu, X; Gao, J; Han, H; Li, Z; Peng, R; Tian, Y; Wang, B; Wang, L; Xu, J; Yao, Q, 2019
)
2.21
"Phenol is a common substance present in many industrial wastewaters and in nonspecific pesticides. "( Effect of phenol on ovarian secretion of 17β-estradiol in common carp Cyprinus carpio.
Das, S; Majumder, S; Mukherjee, D, 2013
)
2.23
"Phenol is a major pollutant in aquatic ecosystems due to its chemical stability, water solubility and environmental mobility. "( Transcriptome profiling of Chironomus kiinensis under phenol stress using Solexa sequencing technology.
Cao, C; Desneux, N; Gao, X; Niu, C; Wang, Z, 2013
)
2.08
"Phenol is a common wastewater contaminant from various industrial processes, including petrochemical refineries and chemical compounds production. "( Relationship between phenol degradation efficiency and microbial community structure in an anaerobic SBR.
Cabrol, L; Carballa, M; Chamy, R; Cruz, L; Donoso-Bravo, A; Lema, JM; Rosenkranz, F; Ruiz-Filippi, G, 2013
)
2.15
"Phenol is an industrially versatile commodity chemical and is currently produced from fossil resources. "( Metabolic engineering of Escherichia coli for the production of phenol from glucose.
Kim, B; Lee, SY; Na, D; Park, H, 2014
)
2.08
"Phenol is a widespread pollutant and a model molecule to study the biodegradation of monoaromatic compounds. "( Biochemical, transcriptional and translational evidences of the phenol-meta-degradation pathway by the hyperthermophilic Sulfolobus solfataricus 98/2.
Auria, R; Casalot, L; Christen, P; Comte, A; Davidson, S; Lorquin, J; Pophillat, M; Simon, G, 2013
)
2.07
"Phenol is a toxic and refractory water pollutant that cannot be completely degraded through common wastewater treatment methods. "( Photocatalytic phenol degradation by immobilized nano ZnO: intermediates & key operating parameters.
Ayati, B; Ganjidoust, H; Malayeri, HZ, 2014
)
2.2
"Phenol is a bulk chemical with lots of applications in the chemical industry. "( Construction of a novel phenol synthetic pathway in Escherichia coli through 4-hydroxybenzoate decarboxylation.
Diao, A; Li, Q; Ma, Y; Miao, L; Zhang, X, 2015
)
2.17
"Phenol is a wastewater contaminant depicting an environmental hazard. "( Anaerobic degradation of increased phenol concentrations in batch assays.
Andert, J; Krebs, M; Wirth, B, 2015
)
2.14
"Phenol is an important chemical engineering material and ubiquitous in industry wastewater, its existence has become a thorny issue in many developed and developing country. "( Rapid Isolation of Phenol Degrading Bacteria by Fourier Transform Infrared (FTIR) Spectroscopy.
Li, F; Liu, CJ; Song, WJ; Wang, SY; Wei, JP, 2015
)
2.19
"Phenol is a highly toxic chemical, topically to both skin and eyes. "( Iatrogenic Phenol Injury Causing Facial Paralysis With Tympanic Membrane and Ossicular Necrosis.
Corrales, CE; Jackler, RK; Santa Maria, PL; Sevy, AB, 2016
)
2.27
"Phenol is a caustic agent."( Efficacy of 80% phenol solution in comparison with cryotherapy in the treatment of common warts of hands.
Banihashemi, M; Family, S; Pezeshkpoor, F; Yazdanpanah, MJ, 2008
)
1.41
"Phenolic lipids are a very diversified group of compounds derived from mono and dihydroxyphenols, i.e., phenol, catechol, resorcinol, and hydroquinone. "( Biological activity of phenolic lipids.
Kozubek, A; Stasiuk, M, 2010
)
2.11
"Phenol cauterization is an excellent surgical method for the treatment of ingrowing toenails, being simple and associated with low morbidity and a high success rate, even over the long term (36 months)."( Partial excision of matrix and phenolic ablation for the treatment of ingrowing toenail: a 36-month follow-up of 197 treated patients.
Balestri, R; Dika, E; Fanti, PA; Piraccini, BM; Rech, G; Vaccari, S, 2010
)
2.09
"Phenol is a neurolytic agent used for management of spasticity in patients with either motoneuron lesions or stroke. "( Phenol increases intracellular [Ca2+] during twitch contractions in intact Xenopus skeletal myofibers.
Hogan, MC; Nogueira, L, 2010
)
3.25
"Phenol is an industrially important compound which has a wide range of applications. "( Bioremediation of phenol by alkaliphilic bacteria isolated from alkaline lake of Lonar, India.
Kanekar, PP; Kelkar, AS; Sarnaik, SS, 1998
)
2.08
"Phenolization is a safe local adjuvant therapy for GCT. "( The influence of adjuvants on local recurrence rate in giant cell tumour of the bone.
Baur-Melnyk, A; Dietz, RA; Dürr, HR; Jansson, V; Pietschmann, MF; Utzschneider, S,
)
1.57
"Phenol is a well known polluting molecule and therefore it is important having data of its behaviour during this process."( Thermodynamic and kinetic study of phenol degradation by a non-catalytic wet air oxidation process.
Boutin, O; Faucherand, R; Ferrasse, JH; Lefèvre, S; Malleret, L; Viand, A, 2011
)
1.37
"Phenol is a commonly used adjuvant associated with local control rates ranging from 9% to 25%."( Similar local control between phenol- and ethanol-treated giant cell tumors of bone.
Chen, CY; Lan, TY; Lin, WH; Wu, K; Yang, RS, 2011
)
1.38
"Phenol is a ubiquitous environmental pollutant and a widely used reference toxicant for many bioassays. "( Phenol toxicity to the aquatic macrophyte Lemna paucicostata.
Brown, MT; Han, T; Park, JS, 2012
)
3.26
"Phenol is known to be an inhibitory substrate, thus Monod, Haldane and logistic kinetic models were applied to evaluate the growth kinetic parameters."( Growth kinetic models for phenol biodegradation in a batch culture of Pseudomonas putida.
Bakhshi, Z; Kariminezhad, E; Mousavi, N; Najafpour, G; Pishgar, R; Taghizade, T, 2011
)
1.39
"As phenols are a class of less investigated CA inhibitors (CAIs) compared to the sulfonamides, and their mechanism of inhibition is less well understood, compounds of the type designed here may be helpful in gaining more insights into these phenomena."( Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV.
Carta, F; Maresca, A; Scozzafava, A; Supuran, CT; Vullo, D, 2013
)
1.17
"Phenol is an industrially key compound that has a wide range of applications and also one of the most commonly found toxic pollutants in wastewaters and groundwater. "( In situ source zone sediment mixing coupled to groundwater biostimulation to enhance phenol natural attenuation.
da Silva, ML; de Oliveira, JC; Schneider, MR; Wendt, MF, 2012
)
2.05
"Phenol cauterization is a chemical equivalent often chosen for treatment of ingrown toenails. "( Enhanced removal of phenol with saline solution over alcohol: an in vitro study.
Becerro de Bengoa Vallejo, R; Cordoba Diaz, D; Cordoba Diaz, M; Losa Iglesias, ME, 2012
)
2.15
"Phenol is a toxic aromatic compound used or produced in many industries and as a result a common component of industrial wastewaters. "( Phenol degradation by halophilic bacteria isolated from hypersaline environments.
Bonfá, MR; Durrant, LR; Grossman, MJ; Mellado, E; Piubeli, F, 2013
)
3.28
"The phenols are an important area of investigation because they are substituents in the humic acids and are common contaminants in water."( Investigations of the reactions of monochloramine and dichloramine with selected phenols: examination of humic acid models and water contaminants.
Fisher, AM; Heasley, VL; Herman, EE; Jacobsen, FE; Miller, EW; Ramirez, AM; Royer, NR; Shellhamer, DF; Whisenand, JM; Zoetewey, DL, 2004
)
1.03
"Phenol is a general protoplasmic poison (denatured protein) with corrosive local effects."( [Acute phenol poisoning].
Todorović, V, 2003
)
1.5
"Phenol is a chemical agent which has been used for spasticity treatment for a long time."( A comparison of the effect of doxorubicin and phenol on the skeletal muscle. May doxorubicin be a new alternative treatment agent for spasticity?
Alparslan, B; Culhaci, N; Cullu, E; Ozkan, I, 2005
)
1.31
"Nonylphenol (NP) is a degradation product of nonylphenol polyethoxylate surfactants and has been reported to occur in water and sediments from urban areas. "( Analysis of nonylphenol isomers in a technical mixture and in water by comprehensive two-dimensional gas chromatography-mass spectrometry.
Horii, Y; Ieda, T; Kannan, K; Ochiai, N; Petrick, G; Yamashita, N, 2005
)
1.18
"Phenol is a neurolytic agent that is widely used by percutaneous retrogasserian injection in the treatment of trigeminal neuralgia. "( Acute unilateral total visual loss after retrogasserian phenol injection for the treatment of trigeminal neuralgia: a case report.
Aydemir, O; Celiker, U; Erol, FS; Onal, SA; Yilmaz, T, 2006
)
2.02
"Phenol is an industrial pollutant and its removal from industrial wastewaters is of great importance. "( Kinetic modelling of phenol co-oxidation using horseradish peroxidase.
Cabral, JM; Carvalho, RH; Fonseca, LP; Lemos, F; Lemos, MA; Vojinović, V, 2006
)
2.1
"Phenol is an intermediate in the metabolism of plants, but it also is a high-volume production compound frequently found in the environment. "( Uptake, removal, accumulation, and phytotoxicity of phenol in willow trees (Salix viminalis).
Trapp, S; Ucisik, AS, 2006
)
2.03
"Phenol is a highly toxic and carcinogenic compound and its biodegradation is very important to meet the environmental regulations. "( Characteristics of phenol biodegradation in saline solutions by monocultures of Pseudomonas aeruginosa and Pseudomonas pseudomallei.
Afzal, M; Iqbal, S; Khalid, ZM; Rauf, S, 2007
)
2.11
"Phenol is a carcinogen to humans and is a serious health concern, even at low concentrations. "( Laser enhanced photo-catalytic removal of phenol from water using p-type NiO semiconductor catalyst.
Gondal, MA; Sayeed, MN; Seddigi, Z, 2008
)
2.05
"Thus phenol is a useful tool for producing hepatic denervation."( Evaluation of topical phenol as a means of producing autonomic denervation of the liver.
Carroll, AM; Lautt, WW, 1984
)
1.04
"Phenol II is a cystogenic chemical that rapidly induces renal cysts, which regress after drug withdrawal. "( Genesis of renal cysts is associated with clusterin expression in experimental cystic disease.
Carone, FA; Kanwar, YS; Manivel, JC; Rosenberg, ME, 1995
)
1.73
"Phenol is a man-made as well as a naturally occurring aromatic compound and an important intermediate in the biodegradation of natural and industrial aromatic compounds. "( Isolation and characterization of phenol-degrading denitrifying bacteria.
van Schie, PM; Young, LY, 1998
)
2.02
"Phenol is a general protoplastic poison which has been in use in medicine and industry for decades. "( Prolonged elimination half-life of phenol after dermal exposure.
Bentur, Y; Berger, Y; Bin-Nun, A; Nachlieli, T; Peled, YJ; Ramon, Y; Shoshani, O; Tabak, A; Ulman, Y, 1998
)
2.02
"Phenol is an inhibitor that in high concentrations changes the sign of the process gain."( Expert system for control of anaerobic digesters.
Chynoweth, DP; Lyberatos, G; Pullammanappallil, PC; Svoronos, SA, 1998
)
1.02
"Phenolization is an effective and safe local adjuvant therapy for GCT. "( Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
Baur, A; Dürr, HR; Jansson, V; Maier, M; Refior, HJ, 1999
)
3.19
"Phenol is a caustic, highly poisonous derivative of coal tar."( Phenol poisoning in three dogs.
Correa, SS; Gieger, TL; Grooters, AM; Johnson, AJ; Taboada, J,
)
2.3
"The phenol hydroxylase is a two-component enzyme encoded by pheA1 and pheA2."( Phenol/cresol degradation by the thermophilic Bacillus thermoglucosidasius A7: cloning and sequence analysis of five genes involved in the pathway.
Bauer, MP; Duffner, FM; Kirchner, U; Müller, R, 2000
)
2.23
"Phenol removal is a key process for the biodegradation of pollutants at high temperatures because even low concentrations of phenol can inhibit microorganisms severely."( Determination of the kinetic parameters of the phenol-degrading thermophile Bacillus themoleovorans sp. A2.
Feitkenhauer, H; Märkl, H; Müller, R; Schnicke, S, 2001
)
1.29
"Phenol blocks are a temporizing procedure during the phase of neurologic recovery."( Current status of functional lower extremity surgery in adult spastic patients.
Jordan, C, 1988
)
1

Effects

Phenols have been shown to influence the cellular proliferation and function of thyroid in experimental models. Phenol has been used for more than 60 years in the treatment of ingrown toenails.

ExcerptReferenceRelevance
"Phenol has a higher adsorption enthalpy since it could form stronger hydrogen bonding on NJ-8."( Adsorption mechanism of phenolic compounds from aqueous solution on hypercrosslinked polymeric adsorbent.
Chen, L; Li, AM; Wang, XJ; Xia, SQ; Zhao, JF, 2004
)
1.35
"Phenols have been shown to influence the cellular proliferation and function of thyroid in experimental models. "( Urinary concentrations of phenols, oxidative stress biomarkers and thyroid cancer: Exploring associations and mediation effects.
Chen, D; Chen, PP; Cui, FP; Deng, YL; Jiang, M; Liu, C; Liu, CP; Lu, TT; Luo, Q; Miao, Y; Shi, T; Wang, LQ; Yang, P; Zeng, JY; Zeng, Q; Zhang, M, 2022
)
2.46
"The phenol nerve block has been widely used in clinical practice for spasticity reduction, but the correlation between the dosage of phenol and its effectiveness has seldom been discussed. "( Optimal Effect of Phenol Block in the Sciatic Nerve of Rats: Standardization of Minimized Dosage and Duration of Application.
Chang, CW; Lin, CC; Tsai, SJ, 2015
)
1.31
"Phenol and xylenes have been removed and naphthalene has attenuated from its maximum extent on day 1357."( Natural attenuation of a plume from an emplaced coal tar creosote source over 14 years.
Barker, JF; Blaine, F; Butler, B; Cooke, C; Fraser, M; Joseph, S, 2008
)
1.07
"Phenol application has been reported to be effective and economical."( Phenol application to angiosarcomas: implications and histologic studies.
Furukawa, F; Kaminaka, C; Yamamoto, Y; Yonei, N, 2009
)
2.52
"Phenolic resins have been used as binders for recycled waste."( Reutilization of thermostable polyester wastes by means of agglomeration with phenolic resins.
Bilbao, E; Correa, M; Laza, JM; León, LM; Rodríguez, M; Vilas, JL, 2010
)
1.31
"Phenols have been linked to serious risks to human and environmental health."( Biofilm coupled with UV irradiation for phenol degradation and change of its community structure.
Xia, S; Yan, N; Zhang, Y; Zhu, J, 2011
)
1.36
"Phenol has been quantitatively extracted from aqueous acidic solutions using TOPO dissolved in kerosene as organic phase."( Extraction of phenol from aqueous solutions by means of supported liquid membrane (MLS) containing tri-n-octyl phosphine oxide (TOPO).
Dhahbi, M; Tayeb, R; Zidi, C, 2011
)
1.45
"Phenol has been used for more than 60 years in the treatment of ingrown toenails. "( Cauterization of the germinal nail matrix using phenol applications of differing durations: a histologic study.
Becerro de Bengoa Vallejo, R; Losa Iglesias, ME; Serrano Pardo, R; Viejo Tirado, F, 2012
)
2.08
"Phenol has the highest solubility and thus was least adsorbed by FSM-16."( Adsorption of some aromatic compounds by a synthetic mesoporous silicate.
Hashizume, H, 2004
)
1.04
"Phenol has a higher adsorption enthalpy since it could form stronger hydrogen bonding on NJ-8."( Adsorption mechanism of phenolic compounds from aqueous solution on hypercrosslinked polymeric adsorbent.
Chen, L; Li, AM; Wang, XJ; Xia, SQ; Zhao, JF, 2004
)
1.35
"Phenol inactivation has been the standard for IBDV tissue collection and international shipment; however, there have been some reports of interference with molecular detection capabilities when using phenol."( Evaluation of FTA paper and phenol for storage, extraction and molecular characterization of infectious bursal disease virus.
Perozo, F; Purvis, LB; Villegas, P, 2006
)
1.35
"Phenol has various medical applications but can cause convulsions and cardiac arrhythmia suggestive of K+ channel block. "( Voltage-dependent inhibition of RCK1 K+ channels by phenol, p-cresol, and benzyl alcohol.
Elliott, AA; Elliott, JR, 1997
)
1.99
"Phenol has been used in adults for local anesthesia during tympanostomy tube insertion."( Phenol as an adjuvant anesthetic for tympanostomy tube insertion.
Belcher, LJ; Naclerio, RM; Orobello, PW; Park, RI; Wetzel, RC, 1991
)
2.45
"Phenol has been proposed to be carboxylated to 4-hydroxybenzoate [(1987) Arch."( Reductive dehydroxylation of 4-hydroxybenzoyl-CoA to benzoyl-CoA in a denitrifying, phenol-degrading Pseudomonas species.
Fuchs, G; Glöckler, R; Tschech, A, 1989
)
1.22
"Phenol has been added to the Coomassie Brilliant Blue G-250 dye reagent used in the standard Bradford protein assay and its effect upon the reagent blank and assay response of fourteen proteins investigated. "( Phenol addition to the Bradford dye binding assay improves sensitivity and gives a characteristic response with different proteins.
Marshall, T; Williams, KM, 1986
)
3.16

Actions

Phenolic compounds cause problems for conventional treatments due to their toxic and inhibitory properties. Phenol was shown to enhance the quantum content of the end-plate currents and to increase the duration of the nerve ending response.

ExcerptReferenceRelevance
"Phenol and glucose inhibit the electrochemical reaction strictly at a concentration of 1 μg/L and 20 mg/L, respectively."( Amperometric nitrate biosensor based on Carbon nanotube/Polypyrrole/Nitrate reductase biofilm electrode.
Can, F; Ergenekon, P; Erhan, E; Korkut Ozoner, S, 2012
)
1.1
"Phenolic compounds cause problems for conventional treatments due to their toxic and inhibitory properties. "( Removal of inhibitory phenolic compounds by biological activated carbon coupled membrane bioreactor.
Thuy, QT; Visvanathan, C, 2006
)
2.09
"Phenol was shown to enhance the quantum content of the end-plate currents and to increase the duration of the nerve ending response. "( [The effect of phenol on the ion currents of the frog motor nerve ending].
Khalilov, IA; Sitdikova, GF; Zefirov, AL, 1996
)
2.09
"Phenol can enhance or impair colour yield depending upon its concentration and the amount and type of protein assayed."( Phenol addition to the Bradford dye binding assay improves sensitivity and gives a characteristic response with different proteins.
Marshall, T; Williams, KM, 1986
)
2.44

Treatment

Phenolic wastewater treatment in a new ozone reactor was investigated. Phenol treatment markedly reduced densities of both calcitonin gene-related peptide (CGRP)-like immunoreactivity (LI) and neuropeptide Y (NPY)-LI-containing fibers. Thimerosal treatment appeared to have little effect compared with heating at 50 degrees C.

ExcerptReferenceRelevance
"Phenol treatment induced a strong degeneration of tumor cells and endothelial cells in the dermis, when compared with nontreated areas. "( Phenol application to angiosarcomas: implications and histologic studies.
Furukawa, F; Kaminaka, C; Yamamoto, Y; Yonei, N, 2009
)
3.24
"The phenol treatment reduced the numbers of both actinomycetes and non-actinomycetes on plates under all three pH conditions."( Isolation and characterization of potent antifungal strains of the Streptomyces violaceusniger clade active against Candida albicans.
Crawford, DL; Kang, MJ; Strap, JL, 2010
)
0.84
"Phenol treatment markedly reduced densities of both calcitonin gene-related peptide (CGRP)-like immunoreactivity (LI)- and neuropeptide Y (NPY)-LI-containing fibers."( [Regeneration of perivascular nerve and role of angiotensin receptors].
Goda, M; Hashikawa, N; Hobara, N; Kawasaki, H; Yoshida, N, 2010
)
1.08
"Phenol and 4-CP were treated alone as a sole carbon and energy source, but only phenol was completely degraded by C."( Enhancement of cometabolic biodegradation of 4-chlorophenol induced with phenol and glucose as carbon sources by Comamonas testosteroni.
Mohedano, AF; Monsalvo, VM; Rodriguez, JJ; Tobajas, M, 2012
)
1.35
"Phenol solutions treated with B."( Evaluation of phenol detoxification by Brassica napus hairy roots, using Allium cepa test.
Agostini, E; Giordana, M; González, PS; Maglione, GA; Paisio, CE; Talano, MA, 2012
)
1.46
"Phenolic wastewater treatment in a new ozone reactor was investigated. "( Adsorption and catalytic oxidation of phenol in a new ozone reactor.
Lin, SH; Wang, CH, 2003
)
2.03
"Polyphenolic-based treatments had the highest level of efficiency in bioburden removal, but interaction and adsorption of this class of chemicals onto biopolymers might lead to serious concerns about toxicity on subsequent reuse."( Different experimental protocols for decontamination affect the cleaning of medical devices. A preliminary electron microscopy analysis.
Caciagli, P; Caola, I; Fedel, M; Guarrera, GM; Motta, A; Nollo, G; Stacchiotti, A; Tessarolo, F, 2007
)
0.82
"Phenol treatment markedly reduced densities of both calcitonin gene-related peptide (CGRP)-like immunoreactivity (LI) and neuropeptide Y (NPY)-LI-containing fibers."( Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide-containing nerves in rat mesenteric arteries.
Goda, M; Hobara, N; Kawasaki, H; Kitamura, Y; Mio, M; Takatori, S; Yoshida, N, 2007
)
1.3
"Phenol treatment followed by ethanol precipitation did not affect the amino acid composition but decreased the apparent molecular weight and N-acetylglucosamine content of human urinary erythropoietin."( An improved method for the purification of human erythropoietin with high in vivo activity from the urine of anemic patients.
Inoue, N; Takeuchi, M; Wada, M, 1994
)
1.01
"For treatment of phenol in the reactor, the maximum biodegradation rate (V (m)) was 1.82 mg l(-1) min(-1); the half-saturation constant (K (s)), 34.95 mg l(-1)."( Biotreatment of phenol-contaminated wastewater in a spiral packed-bed bioreactor.
Lin, CW; Tsai, SL; Yen, CH, 2009
)
1.03
"Treatment by phenol in bactericidal concentration is accompanied by changes in phospholipidic and fatty acid composition of bacterial cell envelope."( [Effect of phenol on Yersinia pseudotuberculosis bacteria cultivated in various media].
Bakholdina, SI; Sanina, NM; Shubin, FN; Solov'eva, TF,
)
0.87
"Pretreatment of phenol-containing water with HOCl or HOBr did not decrease HO* generation, while the same treatment of dimethylamine-containing water considerably reduced HO* generation."( Phenols and amine induced HO* generation during the initial phase of natural water ozonation.
Buffle, MO; von Gunten, U, 2006
)
2.11
"Treatment of phenols with ninhydrin in acidic medium afforded 2-hydroxy-2-(ortho-hydroxy-phenyl/naphthyl)-1,3-dioxoindanes, which being unstable were isolated in their hemiketal forms. "( Identification and evaluation of antioxidant, analgesic/anti-inflammatory activity of the most active ninhydrin-phenol adducts synthesized.
Bansal, P; Barik, A; Prabhakar, KR; Priyadarsini, KI; Reddanna, P; Reddy, BK; Reddy, KM; Unnikrishnan, MK; Veerapur, VP; Vipan, KP, 2006
)
0.91
"Mice treated with phenol had lower levels of neurotransmitters in several brain regions."( Immunological and neurobiochemical alterations induced by repeated oral exposure of phenol in mice.
Coulombe, RA; Hsieh, GC; Parker, RD; Sharma, RP, 1992
)
0.83

Toxicity

Phenol and its derivatives behave as mutagens, teratogens and carcinogens inducing adverse physiological effects and are considered environmental hazards. The search for novel microorganisms able to degrade olive mill wastewaters (OMW) and withstand the toxic effects of the initially high phenolic concentrations is of great scientific and industrial interest.

ExcerptReferenceRelevance
" A toxic effect was caused by concentrations between 30 and 40 ppm during embryogenesis and by concentrations above 40 ppm during larval development."( Embryotoxic effects of environmental chemicals: tests with the South African clawed toad (Xenopus laevis).
Dumpert, K, 1987
)
0.27
" It is concluded that ethanol potentiates benzene toxicity by accelerating (1) hydroxylation of benzene, a rate-limiting step of benzene metabolism and (2) transformation of phenol into highly toxic metabolites."( Effects of ethanol and phenobarbital administration on the metabolism and toxicity of benzene.
Nakajima, T; Okuyama, S; Sato, A; Yonekura, I, 1985
)
0.46
" However, susceptibility to these toxic effects may be related to a balance between activation (phase I) and detoxication (phase II) reactions."( In vitro conjugation of benzene metabolites by human liver: potential influence of interindividual variability on benzene toxicity.
Medinsky, MA; Schlosser, P; Seaton, MJ, 1995
)
0.29
" In vivo and in vitro experiments show that hydroquinone is the most toxic compound, whereas diphenols are more toxic than phenol."( Structure-activity relationship of phenolic compounds (phenol, pyrocatechol and hydroquinone) on natural lymphocytotoxicity of carp (Cyprinus carpio).
Deschaux, P; Khan, NA; Taysse, L; Troutaud, D, 1995
)
0.79
" The pesticides, CAR, TDM, HEP, and CDN, displayed the most acute neurotoxicity and were active at lower proportions of their respective acute LD50 values than were the solvents or the industrial chemicals."( A multidisciplinary approach to toxicological screening: III. Neurobehavioral toxicity.
Cheek, BM; MacPhail, RC; Moser, VC, 1995
)
0.29
" In order to establish a quick and reliable method that accounts for smaller than additive, additive, or greater than additive toxic effects, this study compared the cytotoxicity of 34 binary and ternary chemical mixtures of four structurally different chemicals to HeLa cells."( Human cell line toxicity of binary and ternary chemical mixtures in comparison to individual toxic effects of their components.
Malich, G; Markovic, B; Winder, C, 1998
)
0.3
" Using concentration data from the International Agency for Cancer Research (IARC), biological activity data from the Registry of Toxic Effects of Chemical Substances (RTECS) database and measured and calculated log P values, we have rank ordered some of the important compounds in cigarette smoke condensate by their measured or potential toxicity."( The relative toxicity of compounds in mainstream cigarette smoke condensate.
Hansch, C; Smith, CJ, 2000
)
0.31
" In conclusion, 2-week inhalation exposures to phenol vapor at concentrations up to and including 25 ppm did not produce any adverse effects."( Two-week (ten-day) inhalation toxicity and two-week recovery study of phenol vapor in the rat.
Butala, JH; Dimond, SS; Dunn, BJ; Gingell, R; Hoffman, GM; Morris, CR; Waechter, JM,
)
0.62
" Mating performance and fertility in both generations were similar to controls, and no adverse effects on vaginal cytology or male reproductive function were observed."( Two-generation reproduction study and immunotoxicity screen in rats dosed with phenol via the drinking water.
Butala, JH; Dimond, SS; Dunn, BJ; Gingell, R; House, R; Morrissey, R; Ryan, BM; Selby, R; Waechter, JM,
)
0.36
" The sensitivity, however, for all the strains to step injections of the toxic chemicals was found to increase with an increase in the dilution rate up to a certain dilution rate and then decreased, mainly due to the rapid washing out of the injected chemicals."( Enhancing the sensitivity of a two-stage continuous toxicity monitoring system through the manipulation of the dilution rate.
Gil, GC; Gu, MB; Kim, JH, 2002
)
0.31
"Phenols have a direct toxic effect on human colonic epithelial cells in vitro, which supports the view that dietary fermentation metabolites may be involved in the modulation of chronic bowel inflammation."( Phenol toxicity and conjugation in human colonic epithelial cells.
Brynskov, J; Pedersen, G; Saermark, T, 2002
)
3.2
" Thus little is known about the toxic effects on marine macroalgae."( Review on toxicity testing with marine macroalgae and the need for method standardization--exemplified with copper and phenol.
Eklund, BT; Kautsky, L, 2003
)
0.53
"This study was prompted by toxic responses to disinfecting agents reported in patients after surgical procedures and in sensitized health care personnel."( Cytotoxicity of liquid disinfectants.
Bonifacino, A; Sagripanti, JL, 2000
)
0.31
" This increase in bioluminescence followed a dose dependent response to the toxic chemicals within a specific concentration range."( A bioluminescent sensor for high throughput toxicity classification.
Gu, MB; Kim, BC, 2003
)
0.32
" This is supported by the detection of such adverse effects in plate assays using Escherichia coli tester strains deficient in the OxyR function, but not in OxyR(+) strains."( Nitric oxide promotes strong cytotoxicity of phenolic compounds against Escherichia coli: the influence of antioxidant defenses.
Blanco, M; Escudero, JC; González, MC; Herrera, G; López-Gresa, MP; Martínez, A; O'Connor, JE; Primo, J; Urios, A, 2003
)
0.58
"Determining whether a certain compound is toxic (or inhibitor) or not to a biomass of a WWTP is crucial in order to avoid WWTP malfunction."( An off-line respirometric procedure to determine inhibition and toxicity of biodegradable compounds in biomass from an industrial WWTP.
Baeza, JA; Carrera, J; Casas, C; Guisasola, A; Lafuente, J, 2003
)
0.32
" Whereas atrazine and cyanuric acid showed no significant toxic effect on the cells, phenol reduces growth and activates or induces typical membrane-adaptive responses known for the genus Pseudomonas."( Simultaneous degradation of atrazine and phenol by Pseudomonas sp. strain ADP: effects of toxicity and adaptation.
Heipieper, HJ; Kivisaar, M; Monson, L; Neumann, G; Schauer, F; Teras, R, 2004
)
0.81
" The attached living cell was exposed to toxic chemical such as phenol, which induced the change of SPR angle."( Cell immobilization using self-assembled synthetic oligopeptide and its application to biological toxicity detection using surface plasmon resonance.
Choi, JW; Lee, DB; Lee, W; Lee, WH; Park, KW, 2005
)
0.57
" Compounds with hydroxy groups oriented ortho or para to one another are more toxic than predicted by this equation, and the toxicity trends within this group of compounds are rationalized in terms of the electrophilic chemistry of their oxidation products."( Chemistry-toxicity relationships for the effects of di- and trihydroxybenzenes to Tetrahymena pyriformis.
Aptula, AO; Cronin, MT; Roberts, DW; Schultz, TW, 2005
)
0.33
"This study provides a first attempt from a toxicological perspective to put forward, in general terms and explanations, combined toxic interactions and biostimulation strategy upon nutrient medium to Ralstonia taiwanensis for bioremediation."( Phenol degradation and toxicity assessment upon biostimulation to an indigenous Rhizobium Ralstonia taiwanensis.
Chang, JS; Chen, BY,
)
1.57
" Since CJD brain samples are infectious at all stages of the prion extraction process, we set out to develop a laboratory safe method for prion purification."( Safe method for isolation of prion protein and diagnosis of Creutzfeldt-Jakob disease.
Bastian, FO; Carver, LA; Dash, S; Garry, RF; McDermott, ME; Perry, AS, 2005
)
0.33
", without system interruption due to highly toxic samples."( A multi-channel continuous water toxicity monitoring system: its evaluation and application to water discharged from a power plant.
Gu, MB; Kim, BC, 2005
)
0.33
"Two studies were performed to determine whether topical phenol is a safe and well tolerated local anaesthetic for grommet insertion."( Is phenol a safe local anaesthetic for grommet insertion?
Osborne, J; Robertson, A; Whitwell, R, 2006
)
1.2
" Using a toxic unit (TU) approach, data indicated that ES substances exhibit concentration addition with linear alkylbenzene sulphonate (LAS) and phenols and response addition with alcohols."( Defining the toxic mode of action of ester sulphonates using the joint toxicity of mixtures.
Dearden, JC; Hodges, G; Marshall, SJ; Roberts, DW, 2006
)
0.53
"We describe here a bacterial sensor for electrochemical detection of toxic chemicals."( Genetically engineered pfabA pfabR bacteria: an electrochemical whole cell biosensor for detection of water toxicity.
Biran, D; Erez, T; Neufeld, T; Popovtzer, R; Rishpon, J; Ron, EZ, 2006
)
0.33
" The change on water transpiration of the trees was used to determine toxic effects."( Uptake, removal, accumulation, and phytotoxicity of phenol in willow trees (Salix viminalis).
Trapp, S; Ucisik, AS, 2006
)
0.58
" We simulated solutions (mixtures of standard phenolic compounds) to evaluate the potential toxic effects of phenolic compounds on the rhizobial growth, germination index, plant growth, nodule number, and nitrogen fixation activity of two legume species under laboratory conditions."( Toxicity of phenolic compounds extracted from bark residues of different ages.
Beauchamp, CJ; Machrafi, Y; Prévost, D, 2006
)
0.97
" Formation of complexes between hydroquinone and p-benzoquinone at increasing pH can remove from solution those highly toxic intermediates whose very low EC50 values give rise to a high ecotoxicity even at fairly low concentrations."( Evolution of ecotoxicity upon Fenton's oxidation of phenol in water.
Casas, JA; Molina, CB; Quintanilla, A; Rodriguez, JJ; Zazo, JA, 2007
)
0.59
"Although these procedures are not without adverse effects, this series suggests that the potential benefits outweigh the risks."( Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population.
Ajizian, SJ; Kolaski, K; Koman, LA; Passmore, L; Pasutharnchat, N; Smith, BP, 2008
)
0.58
" The findings indicated that although phenol was toxic to R186, all augmented nutrient sources still exhibited stimulating effects to bacterial growth of R186 in the presence of phenol."( Toxicity assessment upon augmented biostimulation source to indigenous rhizobium Cupriavidus taiwanensis.
Chen, BY; Hsu, SY; Lin, CY, 2009
)
0.62
"The performance of chemical matrixectomies is safe for health care personnel when they are exposed to the vapor of phenol solutions of up to 95% concentration for up to 21 minutes."( Safety of phenol vapor inhalation during performance of chemical matrixectomy to treat ingrown toenails.
Aguilar Franco, J; Becerro de Bengoa Vallejo, R; Bernaola Alonso, M; Losa Iglesias, ME; Tejedor Traspaderne, J; Veiga de Cabo, J, 2008
)
0.96
" The application of aerobic granules in wastewater treatment could provide an improved ability to tolerate toxic chemical shock, particularly at longer exposure times."( Toxicity effect of phenol on aerobic granules.
Liu, QS; Liu, Y; Show, KY; Tay, JH, 2009
)
0.68
" However, the OOMWs remained highly toxic after photo-Fenton oxidation."( Toxicity and organic content characterization of olive oil mill wastewater undergoing a sequential treatment with fungi and photo-Fenton oxidation.
Antunes, SC; Duarte, K; Freitas, AC; Gonçalves, F; Justino, CI; Loureiro, F; Marques, SM; Pereira, R; Rocha-Santos, TA, 2009
)
0.35
" The magnitudes of toxic effect were proportional to concentration whereas kinetics of the response is an indicator for the mechanism of toxicity."( Automatic biodetector of water toxicity (ABTOW) as a tool for examination of phenol and cyanide contaminated water.
Bernas, T; Karczewski, J; Klis, C; Nowak, A; Woznica, A, 2010
)
0.59
" However, little information is available regarding the toxic effects of phenol on aquatic macrophytes."( Phenol toxicity to the aquatic macrophyte Lemna paucicostata.
Brown, MT; Han, T; Park, JS, 2012
)
2.05
" This case report underscores the risks of using phenol for IS and emphasizes the point that the procedure is not innocuous and an adverse outcome including fatality is a possibility."( Death following injection sclerotherapy due to phenol toxicity.
Marraffa, JM; Philip, AT, 2012
)
0.89
"0 × 10(-4) M) in ultrapure water (UW) was eliminated by gamma-irradiation at a dose of 10 kGy, but acute toxicity was dramatically increased, particularly for dose of 1 kGy, due to the formation of more toxic by-products such as hydroquinone, benzoquinone, resorcinol and catechol."( Effect of titanium dioxide nanoparticles on gamma-ray treatment of phenol in different matrices: implications in toxicity toward Daphnia magna.
Jung, J; Kang, SW; Shim, SB; Yoo, J, 2012
)
0.62
" The cytotoxicity test of serial phenol dilution by bovine dentin disc was done to determine a standard toxic material, and the test of this proper phenol by using various millipore combinations was performed to find the suitable dentin substitute."( Cytotoxicity test of dentin bonding agents using millipore filters as dentin substitutes in a dentin barrier test.
Kim, KM; Kim, KN; Kim, MJ; Lee, YK, 2013
)
0.67
"05 % was selected as the standard toxic material."( Cytotoxicity test of dentin bonding agents using millipore filters as dentin substitutes in a dentin barrier test.
Kim, KM; Kim, KN; Kim, MJ; Lee, YK, 2013
)
0.39
" General behavior adverse effects were observed, and poisoned mouse were dissected to observe visceral lesions."( Acute oral toxicity and liver oxidant/antioxidant stress of halogenated benzene, phenol, and diphenyl ether in mice: a comparative and mechanism exploration.
Feng, M; Shi, J; Wang, Z; Wei, Z; Zhang, X, 2013
)
0.62
" This is because in vitro assays cannot provide a complete in vivo dose-response curve from which a point of departure (PoD) for risk assessment can be derived, like the no observed adverse effect level (NOAEL) or the 95 % lower confidence limit of the benchmark dose (BMDL)."( Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
Punt, A; Rietjens, IM; Spenkelink, B; Strikwold, M; Woutersen, RA, 2013
)
0.59
"The search for novel microorganisms able to degrade olive mill wastewaters (OMW) and withstand the toxic effects of the initially high phenolic concentrations is of great scientific and industrial interest."( Enhanced reduction of phenol content and toxicity in olive mill wastewaters by a newly isolated strain of Coriolopsis gallica.
Belbahri, L; Daâssi, D; Mechichi, T; Nasri, M; Vallat, A; Woodward, S, 2014
)
0.92
"Here, we present a new toxicity bioassay (CO2-TOX), able to detect toxic or inhibitory compounds in water samples, based on the quantification of Pseudomonas putida KT2440 CO2 production."( A new P. putida instrumental toxicity bioassay.
Abrevaya, XC; Cortón, E; Figueredo, F, 2015
)
0.42
"It is well established that aquatic wildlife in marine and freshwater of the European Union is exposed to natural and synthetic endocrine disruptor compounds (EDCs) which are able to interfere with the hormonal system causing adverse effects on the intact physiology of organisms."( Toxicity of aqueous mixture of phenol and chlorophenols upon photosensitized oxidation initiated by sunlight or vis-lamp.
Drozdek, E; Foszpańczyk, M; Gmurek, M; Ledakowicz, S, 2018
)
0.77
"We investigated the effects of toxic wastewater generated during the production of phenol-acetone on activated sludge and tested pretreatment methods to selectively remove the toxicity."( Identification of toxic substances in phenol-acetone wastewater on activated sludge and selective toxicity removal performance with ferrous pretreatment.
An, M; Li, J; Liu, Z; Lv, Q; Song, Y; Wang, L; Xu, J; Zhou, Y, 2018
)
0.98
"A microbial fuel cell (MFC) was successfully developed as a toxicity biomonitoring system to enable a quick response to wastewater with unknown toxicity in toxic events."( A quantitative evaluation method for wastewater toxicity based on a microbial fuel cell.
Lu, H; Xing, F; Yu, Y; Zhou, Y, 2019
)
0.51
" Neither the substrate nor the mushroom contained toxic elements beyond the standards of the joint FAO/WHO."( Toxicity and Nutritional Assessment of Extracts of Medicinal Tiger Sawgill Mushroom, Lentinus tigrinus (Agaricomycetes), a Newly Domesticated in Iran.
Ansari, AM; Dowom, SA; Ghadirian, R; Mohammadnejad, S; Pourianfar, HR; Rezaeian, S; Shahtahmasebi, S; Zibaei, S, 2020
)
0.56
" We transformed the bis-aryl ketone structure of BBR to generate novel monocyclic amide-linked phenol derivatives that should possess uric acid excretion activity without adverse properties associated with BBR."( Novel monocyclic amide-linked phenol derivatives without mitochondrial toxicity have potent uric acid-lowering activity.
Ashizawa, N; Iwanaga, T; Kobashi, S; Matsumoto, K; Uda, J, 2021
)
1.13
"Phenol and its derivatives behave as mutagens, teratogens and carcinogens inducing adverse physiological effects and are considered environmental hazards."( Co-substrate-mediated utilization of high concentration of phenol by Aspergillus niger FP7 and reduction of its phytotoxicity on Vigna radiata L.
Bhattacharya, S; Das, A; Krishnan, K; Patil, NA; Sadique, J, 2021
)
2.31
"In the present study, chinonomus riparius larvae were selected as a model organism, and 11 sediment samples from the Xihe River in Shenyang underwent toxicity identification evaluation (TIE) to identify sediment toxic pollutants."( Toxicity Identification Evaluation of Sediments from the Xihe River.
Feng, S; Ke, X; Luan, J; Zhang, F; Zhou, Y, 2021
)
0.62
" As of now, phenol matricectomy combines a low recurrence rate with favourable adverse effect profile and is the preferred modality for matricectomy in grade II and III onychocryptosis."( Efficacy and safety of phenol-based partial matricectomy in treatment of onychocryptosis: A systematic review and meta-analysis.
Choudhary, R; Dogra, S; Narang, T; Narayan Ravivarma, V; Thakur, V; Varthya, SB; Vinay, K, 2022
)
1.41
"Saline chemical wastewater containing ammonia and toxic organic pollutants has been a challenge for conventional wastewater treatment technology."( Removal of ammonia and phenol from saline chemical wastewater by ionizing radiation: Performance, mechanism and toxicity.
He, S; Hu, J; Wang, J; Wang, S, 2022
)
1.03
" This study aimed to determine the adverse effects of OMWS on Enchytraeus albidus and whether the addition of clay and diatomaceous earth can reduce these effects."( Mitigation of OMW toxicity toward Enchytraeus albidus with application of additives.
Hackenberger, BK; Hackenberger, DK; Kallel, A; Kovačević, M; Lončarić, Ž; Stjepanović, N; Trigui, S, 2022
)
0.72
" Accumulating evidence suggests that TCS is considered as a novel endocrine disruptor and may have potential unfavorable effects on human health, but studies on the toxic effect mediated by TCS exposure as well as its underlying mechanisms of action are relatively sparse."( Adverse effects of triclosan exposure on health and potential molecular mechanisms.
Chen, X; Liu, C; Mou, L; Qu, J; Wu, L, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" A pharmacokinetic interaction between PH and HQ is also hypothesized to contribute to the observation."( Pharmacokinetic interaction between benzene metabolites, phenol and hydroquinone, in B6C3F1 mice.
Hoener, BA; Legathe, A; Tozer, TN, 1994
)
0.53
" Pharmacokinetic investigations have shown the drug to be highly bound to blood proteins, mainly serum albumin, and to have a low brain uptake, explaining its lack of sedative effects."( Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
Carrupt, PA; Jolliet, P; Morin, C; Morin, D; Pagliara, A; Rihoux, JP; Testa, B; Tillement, JP; Urien, S, 1998
)
0.3
"The purpose of the present study was to examine the pharmacokinetic characteristics of erianin (2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)-ethyl]-phenol, CAS 95041-90-0), a nature product extracted from Dendrobium chrysotoxum, having notable antitumour activity, after intravenous injection of erianin fat emulsion to beagle dogs."( Liquid chromatographic-mass spectrometry analysis and pharmacokinetic studies of erianin for intravenous injection in dogs.
Hong, M; Ma, R; Sheng, L; Yang, B; Zhou, H, 2009
)
0.55
" Herein, pharmacokinetic properties regarding lipophilicity, plasma protein binding (PPB) and metabolism are analyzed."( Pharmacokinetic properties of enantiomerically pure GluN2B selective NMDA receptor antagonists with 3-benzazepine scaffold.
Ametamey, SM; Börgel, F; Galla, F; Lehmkuhl, K; Schepmann, D; Wünsch, B, 2019
)
0.51
" Pharmacokinetic models were developed for somapacitan and metabolite P1 and used for steady-state assessment in the rat."( Structure identification of circulating metabolites from somapacitan, a long-acting growth hormone derivative, and pharmacokinetics after single and multiple subcutaneous dosing in rats.
Bjelke, M; Helleberg, H; Lindecrona, RH; Thygesen, P, 2022
)
0.72

Compound-Compound Interactions

Crystalized phenol treatment combined with endoscopic pilonidal sinus treatment was safe, tolerable, and achieved fast and durable healing.

ExcerptReferenceRelevance
"In the present work, a synergistic system of pulsed corona discharge combined with TiO(2) photocatalysis has been developed to investigate the degradation rate of phenol solutions by varying experimental conditions of gas bubbling varieties (air, O(2), and Ar), solution pH values, and radical scavenger additives."( Formation of hydrogen peroxide and degradation of phenol in synergistic system of pulsed corona discharge combined with TiO2 photocatalysis.
Li, G; Li, J; Quan, X; Wang, F; Wang, H; Wu, Y, 2007
)
0.79
" The strategy uses solid-phase extraction followed by large volume injection and capillary gas chromatography coupled to mass spectrometry combined with retention time locking libraries (SPE-LVI-GC-MS-RTL)."( New strategies to screen for endocrine-disrupting chemicals in the Portuguese marine environment utilizing large volume injection-capillary gas chromatography-mass spectrometry combined with retention time locking libraries (LVI-GC-MS-RTL).
Almeida, C; Florêncio, MH; Nogueira, JM; Serôdio, P, 2007
)
0.34
" The patient underwent 10 treatment sessions with the 595-nm long-pulsed dye laser followed immediately by the 1450-nm diode laser in combination with intralesional triamcinolone and 5-fluorouracil."( 595-nm long pulsed dye laser and 1450-nm diode laser in combination with intralesional triamcinolone/5-fluorouracil for hypertrophic scarring following a phenol peel.
Friedman, PM; Glaich, AS; Goldberg, LH; Katz, TM, 2010
)
0.56
"To explore the therapeutic processing and nursing for phenol burn patients combined with poisoning."( [Management of phenol burn cases combined with poisoning].
Feng, Q; Xie, EF, 2011
)
0.97
"To compare deep peeling using phenol and PCI combined with trichloroacetic acid (TCA) 20% in treating atrophic acne scars."( Deep peeling using phenol versus percutaneous collagen induction combined with trichloroacetic acid 20% in atrophic post-acne scars; a randomized controlled trial.
Abdel Hay, RM; El Garem, YF; Leheta, TM, 2014
)
1.02
"24 patients with post-acne atrophic scars were randomly divided into two groups; group 1 was subjected to one session of deep peeling using phenol, and group 2 was subjected to four sessions of PCI combined with TCA 20%."( Deep peeling using phenol versus percutaneous collagen induction combined with trichloroacetic acid 20% in atrophic post-acne scars; a randomized controlled trial.
Abdel Hay, RM; El Garem, YF; Leheta, TM, 2014
)
0.93
"The purpose of this study was to examine the safety, effectiveness, and short- and long-term outcomes of crystalized phenol treatment combined with endoscopic pilonidal sinus treatment for pilonidal disease."( Endoscopic Pilonidal Sinus Treatment Combined With Crystalized Phenol Application May Prevent Recurrence.
Celasin, H; Gecim, IE; Goktug, UU, 2017
)
0.9
"Crystalized phenol treatment combined with endoscopic pilonidal sinus treatment was safe, tolerable, and achieved fast and durable healing with no recurrence over an average of 22 months of follow-up."( Endoscopic Pilonidal Sinus Treatment Combined With Crystalized Phenol Application May Prevent Recurrence.
Celasin, H; Gecim, IE; Goktug, UU, 2017
)
1.07
" Our results showed that HA combined with red light irradiation treatment (HA-R-PDT) decreased KF viability, reduced KF collagen production and ECM accumulation, inhibited cell proliferation, suppressed cell invasion and induced cell apoptosis."( Antifibrotic effects of Hypocrellin A combined with LED red light irradiation on keloid fibroblasts by counteracting the TGF-β/Smad/autophagy/apoptosis signalling pathway.
Guo, G; Niu, T; Shi, Y; Tian, Y; Tong, Y; Wang, G, 2021
)
0.62

Bioavailability

Phenol is well absorbed by inhalation, dermal application, and ingestion. To increase the bioavailability and GluN2B affinity, the phenol of the potent benzazepine-based inhibitor, WMS-1410 (3), was replaced bioisosterically by a benzoxazol.

ExcerptReferenceRelevance
" Administration of the reactants together with food decreased the NMOR level in blood 155-fold relative to controls (no food), suggesting that food decreased the absorption rate over a 30-min period."( Effects of phenol and 2,6-dimethoxyphenol (syringol) on in vivo formation of N-nitrosomorpholine in rats.
Issenberg, P; Virk, MS, 1986
)
0.66
" The effect of soil adsorption on the dermal bioavailability of phenol was assessed by applying [14C]phenol alone (P) or with sandy (P-S) or clay (P-C) soil to dermatomed male pig skin samples in flow-through diffusion cells."( Soil decreases the dermal penetration of phenol in male pig in vitro.
Abdel-Rahman, MS; Botrous, MF; Kadry, AM; Skowronski, GA; Turkall, RM, 1994
)
0.79
" The ideal concentration of phenol is uncertain, but may be important because of the high rate of absorption and toxicity."( Cytotoxicity of phenol to musculoskeletal tumours.
Harstrick, A; Müller, RT; Quint, U; Vanhöfer, U, 1996
)
0.93
" Phenol is well absorbed by inhalation, dermal application, and ingestion."( [Acute phenol poisoning].
Todorović, V, 2003
)
1.68
" These results suggest that composting of organic materials improves their agronomic and environmental value by increasing their potential to retain and exchange macro- and micronutrients, and to reduce the bioavailability of organic and inorganic pollutants."( Acid-base properties of humic and fulvic acids formed during composting.
Brunetti, G; Plaza, C; Polo, A; Senesi, N, 2005
)
0.33
" To search for potent and orally bioavailable STAT6 inhibitors, we synthesized a series of 4-benzylaminopyrimidine-5-carboxamide derivatives and evaluated their STAT6 inhibitory activities."( Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitors.
Iwata, M; Koakutsu, A; Kuromitsu, S; Moritomo, H; Nagashima, S; Nagata, H; Ohga, K; Ohta, M; Orita, M; Takeuchi, M; Tsukamoto, S; Yokota, M, 2008
)
0.35
"A series of potent and orally bioavailable 3,4-diaminocyclobutenediones with various amide modifications and substitution on the left side phenyl ring were prepared and found to show significant inhibitory activities towards both CXCR2 and CXCR1 receptors."( Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region.
Aki, C; Biju, P; Chao, J; Dwyer, MP; Fan, X; Ferreira, JA; Fine, J; Fosseta, J; Gonsiorek, W; Hipkin, RW; Lai, G; Lundell, D; Merritt, RJ; Rindgen, D; Taveras, AG; Wu, M; Yu, Y, 2009
)
0.57
" Further research on the bioavailability of the bioactive compounds in Brassica foods will allow backing of recommendations for dietarily effective dosages for nutrition and health."( Selecting sprouts of brassicaceae for optimum phytochemical composition.
Baenas, N; García-Viguera, C; Moreno, DA, 2012
)
0.38
"Phenol was investigated for the ability of TiO2 photocatalysis to increase its bioavailability as an electron donor for denitrification."( Enhanced phenol bioavailability by means of photocatalysis.
Chen, J; Rittmann, BE; Wang, J; Yan, N; Zhang, Y, 2013
)
2.25
" The present study put the basis for bioavailability and preclinical studies, able to define Pl-M extract safety and efficacy."( LC-MS/MS profiling of a mastic leaf phenol enriched extract and its effects on H2O2 and Aβ(25-35) oxidative injury in SK-B-NE(C)-2 cells.
Fiorentino, A; Galasso, S; Marciano, S; Monaco, P; Nocera, P; Pacifico, S; Piccolella, S; Piscopo, V, 2014
)
0.68
"Nanoemulsions have been developed for the oral delivery of poorly bioavailable phenolic compounds that are sensitive to intestinal glucuronidation."( Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions.
Chang, Q; Liao, YH; Liu, CY; Liu, XM; Pan, RL; Yang, FF; Zhou, J; Zhou, M, 2015
)
0.64
"The low bioavailability of dietary phenolic compounds, resulting from poor absorption and high rates of metabolism and excretion, is a concern as it can limit their potential beneficial effects on health."( Potentiation of the bioavailability of blueberry phenolic compounds by co-ingested grape phenolic compounds in mice, revealed by targeted metabolomic profiling in plasma and feces.
Calon, F; Dal-Pan, A; Desjardins, Y; Dubé, P; Dudonné, S; Varin, TV, 2016
)
0.97
" Finally, the study of theoretical physicochemical properties, the observation of low toxicity (hemolysis assay), and the evaluation of oral bioavailability of the TP derivative showed that it is a possible anti-inflammatory drug candidate."(
Castro, RI; Morales-Quintana, L; Valenzuela-Riffo, F, 2019
)
0.51
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" The major obstacle posed in most preclinical studies and clinical trials was the low bioavailability of resveratrol."( Current Update on Preclinical and Clinical Studies of Resveratrol, a Naturally Occurring Phenolic Compound.
Dahiya, R; Dua, K; Gupta, G; Jain, DA; Mishra, A; Samuel, VP,
)
0.35
"The poor bioavailability of polycyclic aromatic hydrocarbons (PAHs) is the main limiting factor for their biodegradation in contaminated sites."( Enhancement of PAHs biodegradation in biosurfactant/phenol system by increasing the bioavailability of PAHs.
Wei, C; Wu, H; Yan, B; Zang, T; Zhang, Y, 2021
)
0.87
" We further investigated the processing effect on the (poly)phenol bioavailability in a crossover postprandial study where three subjects consumed three apple products (freeze-dried snack, hot air-dried snack and pasteurized purée)."( Thermal and non-thermal processing of red-fleshed apple: how are (poly)phenol composition and bioavailability affected?
Ludwig, IA; Macià, A; Motilva, MJ; Pedret, A; Prieto-Diez, N; Romero, MP; Rubió, L; Solà, R; Yuste, S, 2020
)
1.03
" Nanodelivery emerges as a promising way to improve the oral bioavailability and anticancer activity of catechins."( Advances in Nanodelivery of Green Tea Catechins to Enhance the Anticancer Activity.
Huang, Q; Jiang, Y; Jiang, Z; Ma, L, 2021
)
0.62
" The limitations of using polyphenols are also pointed out, which are related to their poor bioavailability and stability, but as the technology is well developed, it is possible to augment the efficacy of polyphenols in the case of melanoma."( Recent Advances in Phenolic Metabolites and Skin Cancer.
Diaconeasa, Z; Pop, TD, 2021
)
1.24
"The present study aimed to evaluate the metabolism and bioavailability of anthocyanins (ACN) and other phenolics from red-fleshed apple (RFA) and to define the intake biomarkers compared to common white-fleshed apple (WFA)."( Phenol metabolic fingerprint and selection of intake biomarkers after acute and sustained consumption of red-fleshed apple versus common apple in humans. The AppleCOR study.
José Motilva, M; Ludwig, I; Macià, A; Pedret, A; Romero, MP; Rubió, L; Salamanca, P; Solà, R; Valls, RM; Yuste, S, 2022
)
2.38
" In this paper, we provide the first comprehensive overview of new hybrid red-fleshed apples, mainly focusing on their (poly)phenolic composition, the effect of processing, the (poly)phenolic bioavailability and the biological effects."( New red-fleshed apple cultivars: a comprehensive review of processing effects, (poly)phenol bioavailability and biological effects.
Ludwig, IA; Motilva, MJ; Romero, MP; Rubió, L; Yuste, S, 2022
)
1.15
" The health effects of tomato (poly)phenolic compounds have been attributed to their metabolites rather than parent compounds and their bioavailability can be modulated by several factors."( Impact of Seasonal Consumption of Local Tomatoes on the Metabolism and Absorption of (Poly)Phenols in Fischer Rats.
Arola-Arnal, A; Calani, L; Cruz-Carrión, Á; Del Rio, D; Mena, P; Ruiz de Azua, MJ; Suárez, M, 2022
)
1.22
" To increase the bioavailability and GluN2B affinity, the phenol of the potent benzazepine-based inhibitor, WMS-1410 (3), was replaced bioisosterically by a benzoxazolone moiety and the phenylbutyl side chain was conformationally restricted in a phenylcyclohexyl substituent."( Phenol-benzoxazolone bioisosteres of GluN2B-NMDA receptor antagonists: Unexpected rearrangement during reductive alkylation with phenylcyclohexanone.
Daniliuc, C; Frehland, B; Fröhlich, R; Goerges, G; Markus, A; Schepmann, D; Schreiber, JA; Seebohm, G; Wünsch, B, 2022
)
2.41
" However, many in vitro studies disregard bioavailability data, a key factor determining responses in humans."( Review of factors affecting citrus polyphenol bioavailability and their importance in designing in vitro, animal, and intervention studies.
Visvanathan, R; Williamson, G, 2022
)
0.99
"Syringic acid (SA) is an active carcinogenesis inhibitor; however, the low bioavailability and unstable functional groups hinder its activity."( In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells.
Cheemanapalli, S; Iyyappan, Y; Kanagaraj, S; Mahesh, Y; Palaniappan, C; Yarrappagaari, S, 2023
)
1.11
" However, the low solubility in water, rapid metabolism and elimination from the body lead to poor bioavailability of Erianin, and greatly hinder its clinical application."( Recent advances of antitumor leading compound Erianin: Mechanisms of action and structural modification.
Li, M; Liu, K; Ma, L; Zhang, Y, 2023
)
0.91

Dosage Studied

Phenol can be degraded efficiently by the as-prepared samples under visible light. Low phenol concentration was conducive to degradation. The optimum calcination temperature and photocatalyst dosage are 650 °C and 0.5°C.

ExcerptRelevanceReference
" In the hypothalamus, a major norepinephrine-containing compartment, the concentrations of norepinephrine significantly decreased by 29 and 40% in groups dosed with 19."( Immunological and neurobiochemical alterations induced by repeated oral exposure of phenol in mice.
Coulombe, RA; Hsieh, GC; Parker, RD; Sharma, RP, 1992
)
0.51
" We observed excesses of cancer of the esophagus, cancer of the kidney, and Hodgkin's disease among workers exposed to phenol, but none of these excesses showed a dose-response relation with exposure to phenol."( Mortality among industrial workers exposed to phenol.
Blair, A; Chandler, J; Dosemeci, M; Stewart, PA; Trush, MA, 1991
)
0.75
" Higher concentrations of NADH relative to phenol were necessary to increase the intensity of staining and to ensure a wide dose-response range of color production with respect to the applied enzyme activities."( A tetrazolium method for staining peroxidase labels in blotting assays.
Hanada, T; Ichikawa, E; Taketa, K, 1986
)
0.53
"5%) for 6 weeks excreted increased amounts of p-cresol, but many excreted negligible amounts so that the overall dose-response relationship was bell shaped."( The effect of saccharin ingestion on the excretion of microbial amino acid metabolites in rat and man.
Lawrie, CA; Renwick, AG, 1987
)
0.27
" Mathematical modelling of the system can provide a reasonably accurate representation of benzene behavior in the body, and should enable dosage to individual or groups of organs to be estimated after occupational exposure."( Pharmacokinetics of benzene in a human after exposure at about the permissible limit.
Sherwood, RJ, 1988
)
0.27
" A neurotoxic dosing regimen (1184 mg/kg/week, sc, for 2 weeks) inhibited both brain and spinal cord NTE (less than or equal to 40%) only marginally 4 and 48 hr postdosing."( Triphenyl phosphite: in vivo and in vitro inhibition of rat neurotoxic esterase.
Grizzle, TB; Lyerly, D; Padilla, SS, 1987
)
0.27
" On a semilogarithmic plot, the dose-response curves for all these compounds were approximately parallel."( Mode of action of butylated hydroxyanisole (BHA) and other phenols in preventing loss of 11 beta-hydroxylase activity in cultured bovine adrenocortical cells.
Aldern, KA; Harris, SE; Hornsby, PJ, 1985
)
0.51
" trans,trans-Muconic acid was identified and was unique to benzene as none was detected in urine of mice dosed orally with phenol, catechol or quinol (250, 150 and 200 mg/kg, respectively)."( trans,trans-Muconic acid, an open-chain urinary metabolite of benzene in mice. Quantification by high-pressure liquid chromatography.
Gad-El Karim, MM; Legator, MS; Ramanujam, VM, 1985
)
0.48
" Phenol blood concentration-time curves after the rectal route of dosing indicate that first pass conjugation by the intestinal mucosa and liver is drastically reduced when compared to the other routes of administration."( First pass conjugation of phenol following rectal administration in rats.
Cassidy, MK; Houston, JB, 1984
)
1.48
" Dose-response curves were developed which showed that one-half the animals became deeply comatose with 540 mumol of intraperitoneal phenol and 100% with 600 mumol."( Encephalopathic effect of phenol in rats.
Brunner, G; Lyftogt, C; Windus-Podehl, G; Zieve, L, 1983
)
0.77
" The immersion dosing method employed for the experiment is discussed with relation to the natural habitat of the fish."( The biotransformation of [14C]phenol in some freshwater fish.
Layiwola, PJ; Linnecar, DF, 1981
)
0.55
" A dose-response study revealed that maximal inhibition of ear swelling (36% to 43%) was observed after intradermal injection of IL-1ra at doses of 10 to 100 micrograms/ear."( Interleukin-1 receptor antagonist suppresses contact hypersensitivity.
Dinarello, CA; Fujisawa, H; Kondo, S; McKenzie, RC; Pastore, S; Sauder, DN; Shivji, GM, 1995
)
0.29
" Repeated dosing produced little or no effect with TCE or PER, marked physiological changes with CCl4, and cumulative toxicity and lethality with DCM."( A multidisciplinary approach to toxicological screening: III. Neurobehavioral toxicity.
Cheek, BM; MacPhail, RC; Moser, VC, 1995
)
0.29
" Differences in the pattern of systemic and neurological effects were also obtained that depended on dosing duration."( A multidisciplinary approach to toxicological screening: IV. Comparison of results.
Berman, E; Elder, JA; Kavlock, RJ; MacPhail, RC; Moser, VC; Narotsky, MG; Schlicht, M, 1995
)
0.29
" 3 and 10 days and 1, 3 and 6 months) and a dose-response experiment."( A unique pattern of hepatocyte proliferation in F344 rats following long-term exposures to low levels of a chemical mixture of groundwater contaminants.
Baker, DC; Benjamin, SA; Constan, AA; Yang, RS, 1995
)
0.29
" Toward gaining sufficient insight into the relevant mechanisms involved in percutaneous absorption of topically applied agents in solution to validate a predictive model, we have 1) estimated porcine stratum corneum/water partition coefficients of two 14C-labeled compounds of interest (phenol and p-nitrophenol), and 2) measured dynamic surface evaporation from dosed excised porcine skin of these two radiolabeled compounds and two 14C-labeled commonly employed vehicles (acetone and ethanol)."( Determination of physicochemical properties of phenol, p-nitrophenol, acetone and ethanol relevant to quantitating their percutaneous absorption in porcine skin.
Brooks, JD; Inman, AO; Monteiro-Riviere, NA; Riviere, JE; Williams, PL, 1994
)
0.72
" A total of 56 8-hr isolated perfused porcine skin flap (IPPSF) topical experiments were used to study the percutaneous absorption and cutaneous distribution of binary mixtures (solute/solvent) of 14C-labeled phenol vs p-nitrophenol (PNP) at two concentrations (4 micrograms/cm2 vs 40 micrograms/cm2) in two vehicles (acetone vs ethanol) under occluded vs nonoccluded dosing conditions."( Quantitative percutaneous absorption and cutaneous distribution of binary mixtures of phenol and para-nitrophenol in isolated perfused porcine skin.
Brooks, JD; Riviere, JE, 1996
)
0.7
" Chemicals reported to be ciliotoxic in other systems were tested on hamster infundibula at various concentrations to determine whether a dose-response inhibition of ciliary beat frequency occurred."( Identification of cigarette smoke components that alter functioning of hamster (Mesocricetus auratus) oviducts in vitro.
DiCarlantonio, G; Gomez, C; Knoll, M; Talbot, P, 1998
)
0.3
" No treatment-related histopathological changes were also observed in any dosed groups."( [13-week subchronic oral toxicity study of phaffia colour in F344 rats].
Mitsumori, K; Onodera, H; Takahashi, M; Takegawa, K; Yasuhara, K, 1997
)
0.3
" An alternative method, synchronous scanning fluorimetry, in which the decrease in catechol concentration was measured under standardized conditions, provided a good dose-response histogram for all the biocides tested."( Rapid evaluation of biocidal activity using a transposon-encoded catechol 2,3-dioxygenase from Pseudomonas putida.
Day, MJ; Edghill, LA; Furr, JR; Russell, AD, 1999
)
0.3
" Sea urchin sperm motility showed a good dose-response relationship to Cd(II) levels as well as exposure time."( Effects of cadmium and phenol on motility and ultrastructure of sea urchin and mussel spermatozoa.
Au, DW; Chiang, MW; Wu, RS, 2000
)
0.62
" Effective doses to produce half block (ED50) of INa or Na conductance (GNa) were obtained from dose-response relations for all solutes used."( ED50 G(Na) block predictions for phenyl substituted and unsubstituted n-alkanols.
Hahin, R; Kondratiev, A, 2001
)
0.31
" The degree of AP attenuation when the nerve was exposed to different concentrations of an alcohol was used to construct dose-response curves."( ED50 AP block predictions for phenyl substituted and unsubstituted n-alkanols.
Hahin, R; Kondratiev, A, 2001
)
0.31
"To verify the dose-response relationship in phenol nerve block and to determine the concentration and volume of phenol injectate required for effective nerve conduction block."( Phenol block of peripheral nerve conduction: Titrating for optimum effect.
Chung, SH; Han, TR; Je Bang, H; Kim, JM; Park, WH; Sung, DH; Woo, EJ, 2001
)
2.01
" Consensus dosing guidelines have been developed and are presented within."( Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
Tilton, AH, 2003
)
0.32
" Operating parameters such as dosage of H(2)O(2) and ferrous ions, pH, suitable carrier gas were found to impact the removal of COD significantly."( Degradation kinetics and mechanisms of phenol in photo-Fenton process.
He, F; Lei, LC, 2004
)
0.59
" The influence of initial concentration and adsorbent dosage was studied."( Sorption of phenol and 4-chlorophenol onto pumice treated with cationic surfactant.
Akbal, F, 2005
)
0.71
" Dose-response analysis clearly revealed that most of the supplemented nutrients tested (except for gluconic acid) synergistically interact with chronic toxicity to phenol, especially at low doses."( Phenol degradation and toxicity assessment upon biostimulation to an indigenous Rhizobium Ralstonia taiwanensis.
Chang, JS; Chen, BY,
)
1.77
" The study was carried out as functions of contact time, pH, initial phenol concentration, red mud dosage and effect of salt addition."( Removal of phenol from aqueous phase by using neutralized red mud.
Aydin, ME; Cengeloglu, Y; Ersoz, M; Tor, A, 2006
)
0.96
" The optimal initial calcium dosage shows linear relationship with the initial phenol concentration, which is useful for practical application."( Calcium enhanced COD removal for the ozonation of phenol solution.
Chen, JH; Hsu, YC; Yang, HC, 2007
)
0.82
" catalyst dosage and 15 mL/min of flowing velocity in the circulating mode."( [Microwave assisted photocatalytic degradation of phenol in aqueous solution].
Hong, J; Liu, YZ; Sun, C; Yang, SG, 2006
)
0.59
" A similar effect was obtained by dosing the fillets with nisin."( Influence of salt, smoke, and high pressure on growth of Listeria monocytogenes and spoilage microflora in cold-smoked dolphinfish (Coryphaena hippurus).
Gómez-Estaca, J; Gómez-Guillén, MC; Montero, P, 2007
)
0.34
" Parameters affecting photocatalytic process such as the catalyst crystallinity, light absorption efficiency, the dosage of catalyst, dopant and phenol concentrations were investigated."( Photocatalytic degradation of phenol in aqueous solutions by Pr-doped TiO2 nanoparticles.
Chiou, CH; Juang, RS, 2007
)
0.83
" In a batch reactor, COD and TOC removals are about 100% and 77% after 120 min in the CWAO of phenol over CeO2-TiO2 1/1 catalyst at reaction temperature of 150 degrees C, the total pressure of 3 MPa, phenol concentration of 1000 mg/L, and catalyst dosage of 4 g/L."( Catalytic wet air oxidation of phenol over CeO2-TiO2 catalyst in the batch reactor and the packed-bed reactor.
Chen, Z; Wang, J; Yang, S; Zhu, W, 2008
)
0.85
" Under a given condition (ClO2 concentration 80 mg/L, microwave power 50 W, contact time 5 min, catalyst dosage 50 g/L, pH 9), phenol removal percentage approached 92."( Treatment of phenol wastewater by microwave-induced ClO2-CuOx/Al203 catalytic oxidation process.
Bi, XY; Huang, JL; Jiang, H; Shi, SJ; Wang, P; Xu, HY, 2007
)
0.91
"Two spectrophotometric methods are proposed for the assay of oxcarbazepine (OXC) in bulk and dosage forms using Folin-Ciocalteu phenol reagent (FCP) and 3-methyl-2-benzothiazolinone hydrazine hydrochloride (MBTH) as reagents."( Use of Folin-Ciocalteu phenol reagent and 3-methyl-2-benzothiazolinone hydrazine hydrochloride in the determination of oxcarbazepine in pharmaceuticals.
Gandhimathi, M; Ravi, TK, 2008
)
0.86
" Increase in the HAp dosage could effectively increase the phenol adsorption percent."( Study the adsorption of phenol from aqueous solution on hydroxyapatite nanopowders.
Chen, Y; Cheng, R; Lin, K; Pan, J; Xu, X, 2009
)
0.9
" No increase in complications with repeat injections was observed, and there was no correlation of complication rates with dosage of either agent."( Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population.
Ajizian, SJ; Kolaski, K; Koman, LA; Passmore, L; Pasutharnchat, N; Smith, BP, 2008
)
0.58
" Finally, we made three key observations after applying SIMS ion microscopy to soil samples from a field experiment receiving (12)C- or (13)C-phenol: (i) cells enriched in (13)C were heterogeneously distributed among soil populations; (ii) (13)C-labelled cells were detected in soil that was dosed a single time with (13)C-phenol; and (iii) in soil that received 12 doses of (13)C-phenol, 27% of the cells in the total community were more than 90% (13)C-labelled."( Dynamic secondary ion mass spectrometry imaging of microbial populations utilizing C-labelled substrates in pure culture and in soil.
Chandra, S; Hanson, BT; Madsen, EL; Pumphrey, GM, 2009
)
0.55
" The decomposition efficiency of total organic compound (eta(TOC)) of HG-UV-OZ with power of UV (P(UV)) of 16W is 54% at applied dosage of ozone per volume sample m(A,in)=1200 mg L(-1) (reaction time t=20 min), while that of HG-OZ without the UV irradiation is 24%."( Pt-catalyzed ozonation of aqueous phenol solution using high-gravity rotating packed bed.
Chang, CC; Chang, CF; Chang, CY; Chen, YH; Chiu, CY; Ji, DR; Tseng, JY; Yu, YH, 2009
)
0.63
" Findings attributable to Proliferol after 24 hours included dose-response elevations in alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, and creatine kinase, which returned to normal after 14 days."( Acute toxicity evaluation of proliferol: a dose-escalating, placebo-controlled study in swine.
Dagenais, S; Green, R; Hite, M; Mayer, J; Wooley, J,
)
0.13
" The influence of several variables was investigated, including pH of solution, NaCl concentration, and dosage of GAC, for their effects on COP phenol degradation in a synthetic saline wastewater."( The investigation of catalytic ozonation and integrated catalytic ozonation/biological processes for the removal of phenol from saline wastewaters.
Alizadeh, R; Khavanin, A; Moussavi, G, 2009
)
0.76
" The dose-response effect of phenol on epithelial barrier function was determined using transepithelial electrical resistance (TER) and FITC-dextran permeability measurements."( Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization.
Betanzos, A; McCall, IC; Miller, GW; Nava, P; Parkos, CA; Weber, DA, 2009
)
1.03
"In the present work, we describe a group of anomalous dose-response (DR) profiles and develop a dynamic model that is able to explain them."( Biphasic toxicodynamic features of some antimicrobial agents on microbial growth: a dynamic mathematical model and its implications on hormesis.
Murado, MA; Vázquez, JA, 2010
)
0.36
" This study evaluates several proliferant dosages develop an optimal dosage that maximizes cell and collagen regeneration."( Effect of prolotherapy on cellular proliferation and collagen deposition in MC3T3-E1 and patellar tendon fibroblast populations.
Brolinson, PG; Ekwueme, EC; Empson, YM; Freeman, JW; Paynter, DM, 2011
)
0.37
" For inspecting the relationship between rate constants and dosage of TiO2, two possible kinetics were proposed in this study."( Determination of reaction rate constants for phenol oxidation using SnO2/Ti anodes coupled with activated carbon adsorption in the presence of TiO2 as catalyst.
Ding, Y; Wang, L; Wang, X; Zhao, Y, 2011
)
0.63
" Particular attention was paid to the effect of initial pH, dosage of H(2)O(2) and to improvement in biodegradation."( Treatment of coking wastewater by an advanced Fenton oxidation process using iron powder and hydrogen peroxide.
Chu, L; Dong, J; Liu, H; Sun, X; Wang, J, 2012
)
0.38
" The yield of oxalic acid is dependent on the amount of ferrous ion dosed since the minimal amount of oxalic acid is formed after the degradation reaction terminates."( Influence of oxalic acid formed on the degradation of phenol by Fenton reagent.
Nakagawa, H; Yamaguchi, E, 2012
)
0.63
" The effects of different operating parameters such as duration of process, catalyst dosage or enzyme concentration, pH of the solution, initial phenol concentration and H(2)O(2) concentration on both processes were examined."( The comparision of Coprinus cinereus peroxidase enzyme and TiO2 catalyst for phenol removal.
Kariminia, HR; Sarkhanpour, R; Sarrafzadeh, MH; Tavakoli, O, 2013
)
0.82
" The batch experiments are conducted to evaluate the effect of pH, phenol concentration, dosage of adsorbent, and contact time on the removal of phenol."( Kinetic and equilibrium studies of adsorptive removal of phenol onto eggshell waste.
Daraei, F; Daraei, H; Mittal, A; Noorisepehr, M, 2013
)
0.87
" Moreover, In vitro cell system analysis confirmed that FRP extract exerts comparable activity with PSP, especially, the sub-fraction sch of FRP showed better antioxidant activity at low dosage and stronger per-oxidant activity at high dosage, and both sch of FRP and PSP can dose-dependent induce HepG2 cells apoptosis, which implied tumor therapeutic effect."( Antioxidant, antityrosinase and antitumor activity comparison: the potential utilization of fibrous root part of Bletilla striata (Thunb.) Reichb.f.
Chen, N; Chen, Y; Ding, X; Ding, Z; Huang, Y; Jiang, F; Jin, B; Li, W, 2013
)
0.39
"05) the thiobarbituric acid reactive substances (TBARS) by 39%-47% and 37%-40% in cooked buffalo meat and chicken patties at lower dosage (22."( Relationship between the solubility, dosage and antioxidant capacity of carnosic acid in raw and cooked ground buffalo meat patties and chicken patties.
Chandran, KR; Kiran, M; Kumar, YP; Muthukumar, M; Naveena, BM; Sen, AR; Shaju, VA; Vaithiyanathan, S, 2013
)
0.39
" Different parameters including of pH (3-12), contact time (20-120 min), phenol concentration (25-400 mg/L) and adsorbent dosage (0."( Preparation of an adsorbent from pumice stone and its adsorption potential for removal of toxic recalcitrant contaminants.
Asgari, G; Rahmani, AR, 2013
)
0.62
"8) and bionanoparticles dosage (0."( Biosorption of phenol onto bionanoparticles from Spirulina sp. LEB 18.
Cadaval, TR; Dotto, GL; Gonçalves, JO; Pinto, LA, 2013
)
0.74
" This is because in vitro assays cannot provide a complete in vivo dose-response curve from which a point of departure (PoD) for risk assessment can be derived, like the no observed adverse effect level (NOAEL) or the 95 % lower confidence limit of the benchmark dose (BMDL)."( Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
Punt, A; Rietjens, IM; Spenkelink, B; Strikwold, M; Woutersen, RA, 2013
)
0.59
" The washed solids required lower cellulase and xylanase dosage than unwashed solids to achieve high sugar yield."( High temperature aqueous ammonia pretreatment and post-washing enhance the high solids enzymatic hydrolysis of corn stover.
Jin, M; Li, BZ; Liu, ZH; Qin, L; Yuan, YJ, 2013
)
0.39
" The final study determined the dose-response relationship for paclitaxel."( Chemical renal denervation in the rat.
Consigny, PM; Davalian, D; Donn, R; Hu, J; Rieser, M; Stolarik, D, 2014
)
0.4
" moles of oxidant utilized in the essays, that lets to estimate the stoichiometric dosage of catalyst as 20 mg/L at pH = 3."( Changes of turbidity during the phenol oxidation by photo-Fenton treatment.
Camarero, LM; Lomas, JM; Perez, J; Villota, N, 2014
)
0.69
" The effects of operating parameters such as initial phenol concentration, light intensity, dosage of ZnO particles, and pH were studied."( Photocatalytic phenol degradation by immobilized nano ZnO: intermediates & key operating parameters.
Ayati, B; Ganjidoust, H; Malayeri, HZ, 2014
)
1
" The interaction of NSD with electronically excited states of Rf and with photogenerated reactive oxygen species (ROS) was evaluated through conventional UV spectroscopy, laser flash photolysis, time-resolved phosphorescence detection of singlet molecular oxygen (O2((1)Δg)), and polarographic dosage of dissolved oxygen."( On the photooxidation of the multifunctional drug niclosamide. A kinetic study in the presence of vitamin B2 and visible light.
Challier, C; García, NA; Gatica, E; Massad, W; Miskoski, S; Natera, J; Pajares, A; Possetto, D, 2015
)
0.42
" Significant release of histamine was detected in blood samples taken 2min after dosing at the highest concentrations tested."( Nonclinical evaluation of the potential for mast cell activation by an erythropoietin analog.
Boyne, M; Chimalakonda, K; Howard, KE; Pang, E; Weaver, JL, 2015
)
0.42
"The phenol nerve block has been widely used in clinical practice for spasticity reduction, but the correlation between the dosage of phenol and its effectiveness has seldom been discussed."( Optimal Effect of Phenol Block in the Sciatic Nerve of Rats: Standardization of Minimized Dosage and Duration of Application.
Chang, CW; Lin, CC; Tsai, SJ, 2015
)
1.31
" The effects of various parameters such as pH, phenol concentration, and H2O2 dosage on catalytic activity were investigated."( A Fe3O4/FeAl2O4 composite coating via plasma electrolytic oxidation on Q235 carbon steel for Fenton-like degradation of phenol.
Jiang, Z; Wang, J; Wang, Y; Xia, Q; Yang, M; Yao, Z, 2016
)
0.9
" Cl(-) and SO4 (2-) exhibited a promoting effect on OG decolorization, and the accelerating rate increased with elevating dosage of ions."( Activated carbon fiber for heterogeneous activation of persulfate: implication for the decolorization of azo dye.
Chen, J; Hong, W; Huang, T; Li, W; Wang, Y; Zhang, L, 2016
)
0.43
" Comparison between the theoretical phenol removal rates deduced by the above two equations and the initial phenol concentration as well as the CRP dosage with the experimental data indicates that the differences between them were less than 20%."( Characteristics and kinetics simulation of controlled-release KMnO4 for phenol remediation.
Dong, S; Huo, M; Xiong, H; Zhou, D; Zou, D,
)
0.64
"Multidose formulations of biotherapeutics, which offer better dosage management and reduced production costs, require the addition of antimicrobial preservatives (APs)."( Correlating the Effects of Antimicrobial Preservatives on Conformational Stability, Aggregation Propensity, and Backbone Flexibility of an IgG1 mAb.
Arora, J; Joshi, SB; Middaugh, CR; Volkin, DB; Weis, DD, 2017
)
0.46
" This study aimed to limit the use of phenol by dose-response studies and investigation into alternative attractants and synergists to phenol."( Dose reduction and alternatives to the phenol pheromone in monitoring and management of the grass grub Costelytra zealandica.
Harper, AR; Suckling, DM; Townsend, RJ; Unelius, CR, 2017
)
1
" Dividing the dose-response curve data obtained with in vitro PBK-based reverse dosimetry, with the CSAF provided a dose-response curve that reflects the consequences of the interindividual variability in phenol kinetics for the developmental toxicity of phenol."( Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Punt, A; Rietjens, IMCM; Spenkelink, B; Strikwold, M; Woutersen, RA, 2017
)
0.84
"Coumarins are a group of phytochemicals that may be beneficial or harmful to health depending on their type and dosage and the matrix that contains them."( In silico genotoxicity of coumarins: application of the Phenol-Explorer food database to functional food science.
Guardado Yordi, E; Matos, MJ; Molina, E; Pérez Martínez, A; Santana, L; Tornes, AC; Uriarte, E, 2017
)
0.7
"The application of identical exposure dosages in different species generally leads to a limited understanding of dose-response patterns because of species-specific factors."( Evaluation of phenol-induced ecotoxicity in two model ciliate species: Population growth dynamics and antioxidant enzyme activity.
Chen, J; Dou, Y; Li, J; Lin, X; Ruan, Y; Warren, A, 2018
)
0.84
" The effects of dosing of granular activated carbon (GAC) and polyaluminum chloride (PACl) on the treatment performance and membrane fouling of anaerobic ceramic membrane bioreactor were investigated for treating phenol- and quinoline-containing wastewater."( Membrane fouling and performance of anaerobic ceramic membrane bioreactor treating phenol- and quinoline-containing wastewater: granular activated carbon vs polyaluminum chloride.
Hu, Z; Ma, C; Pang, C; Wang, S; Wang, W, 2019
)
0.93
" Treatment with relatively high BC dosage exhibited considerable inhibition on Thauera."( Effects of biochar on the phenol treatment performance and microbial communities shift in sequencing batch reactors.
Hou, Y; Jiang, B; Liu, J; Shi, S; Xu, J; Zeng, Q, 2019
)
0.81
"024% respectively at the parametric conditions of adsorbent dosage 3 g/l time 2 h, initial phenol concentration 100 mg/l and pH 8."( Efficacy of spent tea waste as chemically impregnated adsorbent involving ortho-phosphoric and sulphuric acid for abatement of aqueous phenol-isotherm, kinetics and artificial neural network modelling.
Das, P; Jhunjhunwala, A; Kumar, T; Mandal, T; Pathak, U; Roy, A, 2020
)
0.98
" A relationship between the linear slope of the voltage drop stage and the formaldehyde concentration was established through dose-response fitting results."( A quantitative evaluation method for wastewater toxicity based on a microbial fuel cell.
Lu, H; Xing, F; Yu, Y; Zhou, Y, 2019
)
0.51
" The effect of parameters such as pH, agitation speed, contact time and magnetic biochar dosage are validated using design of experiments."( Magnetic palm kernel biochar potential route for phenol removal from wastewater.
Abdullah, EC; Hairuddin, MN; Karri, RR; Khalid, M; Mubarak, NM; Walvekar, R, 2019
)
0.77
" The introduction of this mechanism into the pharmaceutical literature is important given that the mechanism and required reactants are present to carry out the chemistry in dosage forms."( Base-Mediated Oxidative Degradation of Secondary Amides Derived from p-Amino Phenol to Primary Amides in Drug Molecules.
Ginnetti, A; Nanda, KK; Wuelfing, WP, 2020
)
0.79
"Linear models provided a simple and reliable tool to aid optimal monitoring of IGF-I by predicting mean and peak IGF-I levels based on an IGF-I sample following dosing of somapacitan."( Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once-Weekly Somapacitan.
Agersø, H; Højby Rasmussen, M; Juul Kildemoes, R; Overgaard, RV, 2021
)
0.62
"61% under the initial value of pH 4, an iron dosage of 50 g/L, a mass ratio of iron/carbon of 1:1, and the initial phenol concentration of 100 mg/L."( Research on dynamics and mechanism of treatment on phenol simulated wastewater by the ultrasound cooperated electro-assisted micro-electrolysis.
Cai, Y; Hu, Y; Li, J; Qiu, W; Qu, G; Ren, N; Zou, H, 2021
)
1.08
"Ecust004 treatment decreased the growth and proliferation of MDA-MB-231 and MCF7 cells at a lower dosage than Erianin."( Ecust004 Suppresses Breast Cancer Cell Growth, Invasion, and Migration via EMT Regulation.
Hu, X; Huang, J; Huang, L; Liang, Y; Liu, Z; Nie, H; Sun, L; Wu, F, 2021
)
0.62
"Somapacitan is a growth hormone derivative approved for once-weekly treatment of growth hormone deficiency in adults and currently in clinical development for once-weekly dosing in children."( Structure identification of circulating metabolites from somapacitan, a long-acting growth hormone derivative, and pharmacokinetics after single and multiple subcutaneous dosing in rats.
Bjelke, M; Helleberg, H; Lindecrona, RH; Thygesen, P, 2022
)
0.72
" The aim of this study was to provide clinical guidance on dosing and titration of the novel long-acting GH derivative somapacitan based on analyses of somapacitan dose-insulin-like growth factor I (IGF-I) responses in AGHD patients."( Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
Biller, BMK; Hollensen, C; Johannsson, G; Kildemoes, RJ; Rasmussen, MH; Takahashi, Y, 2022
)
0.72
"Analyses of dosing information, 4364 somapacitan concentration samples and 4880 IGF-I samples from 330 AGHD patients treated with somapacitan in three phase 3 trials."( Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
Biller, BMK; Hollensen, C; Johannsson, G; Kildemoes, RJ; Rasmussen, MH; Takahashi, Y, 2022
)
0.72
" Simulations of IGF-I SDS profiles confirmed the appropriate time for IGF-I sampling to be 3-4 days after somapacitan dosing and supported somapacitan administration with up to 3 days delay in case of missed dosing."( Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
Biller, BMK; Hollensen, C; Johannsson, G; Kildemoes, RJ; Rasmussen, MH; Takahashi, Y, 2022
)
0.72
"This study extends the knowledge of the somapacitan dose-IGF-I response and provides information on clinical dosing of once-weekly somapacitan in patients with AGHD."( Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
Biller, BMK; Hollensen, C; Johannsson, G; Kildemoes, RJ; Rasmussen, MH; Takahashi, Y, 2022
)
0.72
" Overall, exposure to BPA increased the odds of having endometriosis, and there appeared to be a dose-response relationship."( Association of environmental phenols with endometriosis and uterine leiomyoma: An analysis of NHANES, 2003-2006.
Eata, V; Lee, AW, 2022
)
1.01
" The photocatalyst dosage had the least significant impact on degradation."( Influence of wastewater matrix on the visible light degradation of phenol using AgCl/Bi
Adenuga, DO; Chirwa, EMN; Tichapondwa, SM, 2023
)
1.15
" According to the field test, when the pH of the wastewater is 9, the field test temperature is 20 °C, the adsorption time is 30 min and the optimal dosing ratio of nitrogen-doped gasification slag (HX-NGS) to the wastewater is 1:4, HX-NGS has the best removal effect on COD, volatile phenol and ammonia nitrogen in the wastewater from the semicarbon."( Key technology of HX-NGS adsorption for treating organic matter in orchid carbon wastewater.
Cai, XL; Guo, L; Huang, JW; Wang, HX; Wen, JF; Xu, YH, 2023
)
1.09
" In this review, we analyze selective (poly)phenol mechanisms in senescent and cancer cells to discriminate between in vitro and in vivo evidence and human applications considering (poly)phenol bioavailability, the influence of the gut microbiota, and their dose-response effects."( Cell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols.
Buriani, A; Cassidy, A; Davinelli, S; De Vivo, I; Fortinguerra, S; Scapagnini, G; Sorrenti, V, 2023
)
1.39
" Future studies should be conducted with increased DB dosage and employ apple (poly)phenols supplemented in the form of extracts or sugar-free powder."( Effect of (poly)phenol-rich 'Daux Belan' apple supplementation on diet-induced obesity and glucose intolerance in C57BL/6NCrl mice.
Kienesberger, PC; Pulinilkunnil, T; Rupasinghe, HPV; Yu, CHJ, 2023
)
1.48
" The outcomes of the investigation revealed that the optimal preparation conditions for the catalyst were achieved at a temperature of 40 °C, a pH value of 5, and a relative dosage of Cu-HAP at 100 mg/g."( Ion exchange synthesis of copper-based hydroxyapatite for the catalytic degradation of phenol.
Chen, W; Peng, Y; Ren, D; Wang, Z; Zhang, S; Zhang, X, 2023
)
1.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
disinfectantAn antimicrobial agent that is applied to non-living objects to destroy harmful microorganisms or to inhibit their activity.
antiseptic drugA substance used locally on humans and other animals to destroy harmful microorganisms or to inhibit their activity (cf. disinfectants, which destroy microorganisms found on non-living objects, and antibiotics, which can be transported through the lymphatic system to destroy bacteria within the body).
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (14)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase I - Functionalization of compounds69175
Cytochrome P450 - arranged by substrate type30110
Xenobiotics450
CYP2E1 reactions019
Phase II - Conjugation of compounds73122
Cytosolic sulfonation of small molecules1747
phenol degradation I (aerobic)18
phenyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP39
diphenyl ethers degradation612
salicylate degradation III04
superpathway of aromatic compound degradation3349
Benzene metabolism010

Protein Targets (69)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency25.11890.004023.8416100.0000AID485290
RAR-related orphan receptor gammaMus musculus (house mouse)Potency29.84930.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency136.99530.000221.22318,912.5098AID588515
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency52.65940.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency381.92110.000817.505159.3239AID1159527; AID1159531; AID588544
estrogen nuclear receptor alphaHomo sapiens (human)Potency26.12950.000229.305416,493.5996AID743069; AID743078
cytochrome P450 2D6Homo sapiens (human)Potency38.90180.00108.379861.1304AID1645840
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency26.60110.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency1,122.02000.001019.414170.9645AID588537
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency53.09100.023723.228263.5986AID743222
alpha-galactosidaseHomo sapiens (human)Potency10.00004.466818.391635.4813AID2107
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency43.27710.001723.839378.1014AID743083
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency61.13060.000323.4451159.6830AID743066
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency538.47940.000627.21521,122.0200AID651741
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency2.23870.009610.525035.4813AID1479145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain B, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain A, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain B, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain A, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain B, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain A, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain B, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain A, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain B, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain A, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain B, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain A, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Chain B, Penicillin AmidohydrolaseEscherichia coliKi82.000082.00002,297.80005,850.0000AID977610
Carbonic anhydrase 12Homo sapiens (human)Ki131.46320.00021.10439.9000AID1058080; AID1798641; AID462279; AID496922; AID501912; AID568365; AID725593; AID729573
Carbonic anhydrase 1Homo sapiens (human)IC50 (µMol)4.63000.00582.14107.9000AID1803136
Carbonic anhydrase 1Homo sapiens (human)Ki90.93770.00001.372610.0000AID1058083; AID1238072; AID1257050; AID1798641; AID1803139; AID1803140; AID1803217; AID462270; AID496913; AID501903; AID568362; AID588186; AID725595; AID729582
Carbonic anhydrase 2Homo sapiens (human)IC50 (µMol)4.63000.00021.10608.3000AID1803136
Carbonic anhydrase 2Homo sapiens (human)Ki86.80220.00000.72369.9200AID1058082; AID1238073; AID1257051; AID1798641; AID1803139; AID1803140; AID1803217; AID462271; AID496914; AID501904; AID568363; AID588187; AID725594; AID725602; AID729580
Carbonic anhydrase 3Homo sapiens (human)Ki152.76250.00022.010210.0000AID1798641; AID462272; AID496915; AID501905; AID729581
Cannabinoid receptor 1Rattus norvegicus (Norway rat)Ki500.00000.00020.566510.0000AID496923
Carbonic anhydrase 4Homo sapiens (human)Ki110.20680.00021.97209.9200AID1798641; AID1803139; AID1803140; AID1803217; AID462273; AID496916; AID501906; AID729579
Carbonic anhydrase 6Homo sapiens (human)IC50 (µMol)4.63000.02001.33175.7900AID1803136
Carbonic anhydrase 6Homo sapiens (human)Ki166.93190.00011.47109.9200AID1798641; AID1803139; AID1803217; AID462276; AID496919; AID501909; AID729576
Adenosine receptor A1Rattus norvegicus (Norway rat)Ki187.90000.00011.20929.9700AID462275; AID462279; AID462281
Adenosine receptor A2aRattus norvegicus (Norway rat)Ki360.75000.00021.494010.0000AID462277; AID462281
Carbonic anhydrase 5A, mitochondrialHomo sapiens (human)Ki206.58750.00001.27259.9000AID1798641; AID462274; AID496917; AID501907; AID729578
Carbonic anhydrase 7Homo sapiens (human)Ki316.46250.00021.37379.9000AID1798641; AID462277; AID496920; AID501910; AID729575
Carbonic anhydrase Mycobacterium tuberculosis H37RvKi79.00000.01202.72389.1200AID588182
Beta-carbonic anhydrase 1Mycobacterium tuberculosis H37RvKi64.00000.00483.38419.8400AID588183
Carbonic anhydrase 9Homo sapiens (human)Ki125.19000.00010.78749.9000AID1058081; AID1257052; AID1798641; AID462278; AID496921; AID502077; AID568364; AID725592; AID729574
Carbonic anhydraseDicentrarchus labrax (European seabass)Ki13.70002.13005.53339.4100AID607497
Carbonic anhydrase Cryptococcus neoformans var. grubiiKi25.90000.01000.73648.3470AID588185
Carbonic anhydrase 3Bos taurus (cattle)IC50 (µMol)4.63004.63005.21005.7900AID1803136
Carbonic anhydrase 3Bos taurus (cattle)Ki9.64600.11303.88159.7100AID1803140; AID1803217
Carbonic anhydraseCandida albicans SC5314Ki17.30000.01051.44448.3470AID588184
Carbonic anhydrase 13Homo sapiens (human)Ki697.00000.00031.23099.8000AID501913; AID729572
Carbonic anhydrase 15Mus musculus (house mouse)Ki10.50000.00091.884610.0000AID331293; AID496925; AID501915
Carbonic anhydrase 13Mus musculus (house mouse)Ki259.31430.00021.39749.9000AID1798641; AID462280; AID496923
Carbonic anhydrase 14Homo sapiens (human)Ki154.96250.00021.50999.9000AID1798641; AID462281; AID496924; AID501914; AID729571
Carbonic anhydrase 5B, mitochondrialHomo sapiens (human)Ki285.15000.00001.34129.9700AID1798641; AID462275; AID496918; AID501908; AID729577
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, LysozymeTequatrovirus T4Kd91.000056.000082.3333100.0000AID977611
Chain A, LysozymeTequatrovirus T4Kd91.000056.000082.3333100.0000AID977611
Chain A, LysozymeTequatrovirus T4Kd91.000056.000082.3333100.0000AID977611
Chain A, LysozymeTequatrovirus T4Kd91.000056.000082.3333100.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd16,500.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd16,500.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd16,500.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd16,500.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd16,500.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd16,500.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd16,500.0000460.00004,612.000016,500.0000AID977611
EndolysinTequatrovirus T4Kd98.47503.00003.00003.0000AID238123; AID728447; AID728448; AID728450
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)EC50 (µMol)50,500.00000.00112.000910.0000AID72641; AID72642
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)EC50 (µMol)50,500.00000.00141.957810.0000AID72641; AID72642
Gamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)EC50 (µMol)50,500.00000.00141.776810.0000AID72641; AID72642
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sulfotransferase 1A1 Rattus norvegicus (Norway rat)Km19.00005.00007.571410.0000AID39219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (33)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
response to bacteriumCarbonic anhydrase 3Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 3Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
post-embryonic developmentGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
adult behaviorGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of bitter tasteCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 7Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 7Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 7Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 7Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 7Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 7Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chemical synaptic transmissionGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
inner ear receptor cell developmentGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
innervationGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cochlea developmentGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
regulation of membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 13Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 14Homo sapiens (human)
response to bacteriumCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 3Homo sapiens (human)
protein bindingCarbonic anhydrase 3Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 3Homo sapiens (human)
nickel cation bindingCarbonic anhydrase 3Homo sapiens (human)
GABA receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
protein bindingGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 6Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 6Homo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A2aRattus norvegicus (Norway rat)
carbonate dehydratase activityCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 7Homo sapiens (human)
GABA receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 3Bos taurus (cattle)
protein bindingCarbonic anhydrase 13Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 13Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 13Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 14Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 14Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (40)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytoplasmCarbonic anhydrase 3Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
axonGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
extracellular regionCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
cytosolCarbonic anhydrase 6Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
Golgi membraneAdenosine receptor A2aRattus norvegicus (Norway rat)
mitochondrial matrixCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytosolCarbonic anhydrase 7Homo sapiens (human)
cytoplasmCarbonic anhydrase 7Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
extracellular exosomeGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
cytosolCarbonic anhydrase 13Homo sapiens (human)
myelin sheathCarbonic anhydrase 13Homo sapiens (human)
intracellular membrane-bounded organelleCarbonic anhydrase 13Homo sapiens (human)
cytoplasmCarbonic anhydrase 13Homo sapiens (human)
cytosolCarbonic anhydrase 13Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
membraneCarbonic anhydrase 14Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 14Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 14Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (267)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID26261Partition coefficient (logD7.2)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID588184Inhibition of Candida albicans recombinant Nce103 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID282839Cytotoxicity against human CEM/VLB cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID462278Inhibition of human CA9 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID568362Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.
AID19211Calculated partition coefficient (clogP)2001Bioorganic & medicinal chemistry letters, Sep-03, Volume: 11, Issue:17
Utility of boron clusters for drug design. Hansch-fujita hydrophobic parameters pi of dicarba-closo-dodecaboranyl groups.
AID1331300Lipophilicity, log D of the compound at pH 7.4 by HPLC method
AID310932Permeability across human Skin2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID15680Partition coefficient (logP)1993Journal of medicinal chemistry, Nov-26, Volume: 36, Issue:24
Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations.
AID728444Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102H double mutant expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 1 mM at pH 5.4 by circular dichroism analysis2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
AID1449742Selectivity ratio of Ki for recombinant human carbonic anhydrase 2 to Ki for recombinant Malassezia globosa beta-carbonic anhydrase2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Inhibition of Malassezia globosa carbonic anhydrase with phenols.
AID342464Dissociation constant, pKa of the compound2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
The many roles for fluorine in medicinal chemistry.
AID1656918Acid dissociation constant, pKa of the compound by UV spectral absorption analysis2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Phosphine boranes as less hydrophobic building blocks than alkanes and silanes: Structure-property relationship and estrogen-receptor-modulating potency of 4-phosphinophenol derivatives.
AID72642Potentiation of GABA responses at human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-22002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.
AID159270Toxicity determined using Microtox Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID23714Partition coefficient (logP)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID310933Permeability across PAMPA membrane after 7 hrs2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID729571Inhibition of human carbonic anhydrase 14 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID721702Dissociation constant, pKa of the compound2013Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
Increased hydrophobicity and estrogenic activity of simple phenols with silicon and germanium-containing substituents.
AID1238073Inhibition of human erythrocytes CA2 using 4-nitrophenylacetate as substrate by esterase assay2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and carbonic anhydrase inhibitory properties of novel uracil derivatives.
AID303044Cytotoxicity against human MIA PaCa2 cells after 72 hrs by MTT assay2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.
AID26793Partition coefficient (logP)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1145610Dissociation constant, pKa of the compound at pH 6.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1134603Oleyl alcohol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID729573Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID1257051Inhibition of human carbonic anhydrase 2 incubated for 15 mins prior to testing by stopped flow CO2 hydration assay2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives.
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID501915Inhibition of mouse carbonic anhydrase 15 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID462270Inhibition of human CA1 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID266763Membrane retention in 70% silicon-30% IPM membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID501913Inhibition of human carbonic anhydrase 13 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID39219Apparent Michaelis constant (Km) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID116726Acute toxicity measured as median lethal dose in mice1980Journal of medicinal chemistry, Dec, Volume: 23, Issue:12
Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents.
AID1125765Partition coefficient, log P of the compound in methanol-water mixture at 0.25 mg/ml by HPLC analysis2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Polyfluorinated bis-styrylbenzenes as amyloid-β plaque binding ligands.
AID588187Inhibition of human recombinant alpha-carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID729574Inhibition of human carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID266765Effective permeability coefficient in 70% silicon-30% IPM membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID1238072Inhibition of human erythrocytes CA1 using 4-nitrophenylacetate as substrate by esterase assay2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and carbonic anhydrase inhibitory properties of novel uracil derivatives.
AID725604Inhibition of Mycobacterium tuberculosis Rv3588c beta-carbonic anhydrase by stopped flow assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity.
AID28957Partition coefficient (logP)2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Rational determination of transfer free energies of small drugs across the water-oil interface.
AID24226Partition coefficient (logP)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.
AID687184Dissociation constant, pKa of the compound at pH 2 to 3 by spectrophotometric analysis2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
AID496920Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID462274Inhibition of human CA5A by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID447577Agonist activity at GABAA assessed as enhancement of channel current2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds.
AID1571463Antiproliferative activity against human IN1760 cells after 72 hrs by sulforhodamine B assay2018MedChemComm, Nov-01, Volume: 9, Issue:11
Towards identifying potent new hits for glioblastoma.
AID729580Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID1291712Protective activity against Naja kaouthia venom-induced mortality in Swiss albino mouse at 100 mmol, iv by measuring venom LD50 preincubated with venom for 1 hr followed by administration to mouse measured after 24 hrs (Rvb = 2.82 ug)2016European journal of medicinal chemistry, May-23, Volume: 114Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
AID1312213Substrate activity at mushroom tyrosinase assessed as Km for monophenolase activity in presence H2O2 by spectrophotometry based Michaelis-Menten plot analysis2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Characterization of the action of tyrosinase on resorcinols.
AID588183Inhibition of Mycobacterium tuberculosis recombinant Rv1284 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID1058080Inhibition of human recombinant carbonic anhydrase 12-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
AID729575Inhibition of human carbonic anhydrase 7 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID725717Inhibition of Mycobacterium tuberculosis Rv1284 beta-carbonic anhydrase by stopped flow assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity.
AID462275Inhibition of human CA5B by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID114268Hypnotic activity was measured as dose which causes loss of righting reflex for a minimum period of 30s in 50% of mice1980Journal of medicinal chemistry, Dec, Volume: 23, Issue:12
Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents.
AID588182Inhibition of Mycobacterium tuberculosis recombinant Rv3273 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID725594Inhibition of human CA2 by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
AID501905Inhibition of human carbonic anhydrase 3 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID385221Lipophilicity, log P of the compound2008Journal of medicinal chemistry, May-08, Volume: 51, Issue:9
Synthesis and screening of mono- and di-aryl technetium and rhenium metallocarboranes. A new class of probes for the estrogen receptor.
AID227718Binding energy by using the equation deltaG obsd = -RT ln KD1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Functional group contributions to drug-receptor interactions.
AID729579Inhibition of human carbonic anhydrase 4 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID1058082Inhibition of human recombinant carbonic anhydrase 2-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
AID282837Cytotoxicity against human MCF7 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID282835Cytotoxicity against mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID266767Membrane retention in 100% silicon membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID588185Inhibition of Cryptococcus neoformans recombinant Can2 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID1058083Inhibition of human recombinant carbonic anhydrase 1-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
AID496922Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID1238074Competitive inhibition of human erythrocytes CA1 using 4-nitrophenylacetate as substrate by Lineweaver-Burk plot analysis2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and carbonic anhydrase inhibitory properties of novel uracil derivatives.
AID288185Permeability coefficient through artificial membrane in presence of stirred water layer2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1149269Antimicrobial activity against Aspergillus niger1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Quantitative structure-activity relationships. 2. A mixed approach, based on Hansch and Free-Wilson Analysis.
AID588196Selectivity ratio of Ki for human recombinant alpha-carbonic anhydrase 2 to Ki for Candida albicans recombinant Nce103 beta-carbonic anhydrase2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID496921Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID501907Inhibition of human carbonic anhydrase 5a after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID721703Octanol-water partition coefficient, log P of the compound by HPLC analysis2013Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
Increased hydrophobicity and estrogenic activity of simple phenols with silicon and germanium-containing substituents.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1127996Toxicity in fluoroquinolone-resistant Staphylococcus aureus 1199B expressing NorA after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID266761Effective permeability coefficient in 100% silicon membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID282833Activity against caspase-mediated apoptosis in mouse L1210 cells at 0.1 mM2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID266760Permeability coefficient in silicon membrane using diffusion cells2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID266766Dissociation constant, pKa of the compound2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID760337Toxicity in mouse2013ACS medicinal chemistry letters, Aug-08, Volume: 4, Issue:8
Adenosine Dioxolane Nucleoside Phosphoramidates as Antiviral Agents for Human Immunodeficiency and Hepatitis B Viruses.
AID636076Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by lactate dehydrogenase assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents.
AID288184Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID303043Cytotoxicity against human MIA PaCa2 cells after 4 hrs by MTT assay2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.
AID501906Inhibition of human carbonic anhydrase 4 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID19255Partition coefficient (logP)1993Journal of medicinal chemistry, Nov-26, Volume: 36, Issue:24
Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations.
AID644414Lipophilicity, log D of the compound in octanol-water at pH 7.4 by reverse-phase HPLC analysis2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).
AID462279Inhibition of human CA12 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1145387Partition coefficient, log P of the compound by HPLC analysis1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Direct measurement of octanol-water partition coefficients by high-pressure liquid chromatography.
AID40623Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined.1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID23101Acidity of compound was determined1981Journal of medicinal chemistry, Nov, Volume: 24, Issue:11
Acidic epinephrine analogues derived from 1H, 3H-2,1,3-benzothiadiazole 2,2-dioxide and from trifluoromethanesulfonanilide. A new synthesis of 1H,3H-2,1,3-benzothiadiazole 2,2-dioxide.
AID588194Selectivity ratio of Ki for human recombinant alpha-carbonic anhydrase 2 to Ki for Mycobacterium tuberculosis recombinant Rv3273 beta-carbonic anhydrase2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID729578Inhibition of human carbonic anhydrase 5A preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID725593Inhibition of human CA12 by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
AID462272Inhibition of human CA3 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID310931Partition coefficient, log P of the compound2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID725592Inhibition of human CA9 by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID729581Inhibition of human carbonic anhydrase 3 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID725605Inhibition of Mycobacterium tuberculosis Rv3273 beta-carbonic anhydrase by stopped flow assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity.
AID16569171-Octanol-water partition coefficient, log P of the compound by HPLC analysis2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Phosphine boranes as less hydrophobic building blocks than alkanes and silanes: Structure-property relationship and estrogen-receptor-modulating potency of 4-phosphinophenol derivatives.
AID568363Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.
AID501904Inhibition of human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID501908Inhibition of human carbonic anhydrase 5b after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID496914Inhibition of human carbonic anhydrase 2 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496913Inhibition of human carbonic anhydrase 1 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID447576Binding affinity to apoferritin by isothermal titration calorimetry2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds.
AID23978Capacity ratio (log k'w)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID288191Membrane retention in permeability experiment with artificial membrane2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID607497Inhibition of Dicentrarchus labrax CA using 4-nitrophenylacetate substrate by esterase assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.
AID266769Membrane retention in 100% IPM membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID496917Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID588197Selectivity ratio of Ki for human recombinant alpha-carbonic anhydrase 2 to Ki for Cryptococcus neoformans recombinant Can2 beta-carbonic anhydrase2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID501909Inhibition of human carbonic anhydrase 6 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID39220Maximal velocity (Vmax) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID711584Dissociation constant, pKa of the compound2011Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8
Synopsis of some recent tactical application of bioisosteres in drug design.
AID1203814Toxicity in mouse2015Journal of medicinal chemistry, Apr-23, Volume: 58, Issue:8
β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate Forms.
AID1145606Octanol-aqueous phase partition coefficient, log P of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID26287Partition coefficient (logD3.0)1998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID343070Dissociation constant, pKa of the compound2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitors.
AID501914Inhibition of human carbonic anhydrase 14 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID588195Selectivity ratio of Ki for human recombinant alpha-carbonic anhydrase 2 to Ki for Mycobacterium tuberculosis recombinant Rv1284 beta-carbonic anhydrase2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID496915Inhibition of human carbonic anhydrase 3 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID728449Binding affinity to Enterobacteria phage T4 lysozyme L99A mutant expressed in Escherichia coli BL21(DE3) by isothermal titration calorimetry2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
AID40936Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I501982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1291710Protective activity against Daboia russellii venom-induced mortality by measuring venom LD50 in Swiss albino mouse at 100 mmol, iv preincubated with venom for 1 hr followed by administration to mouse measured after 24 hrs (Rvb = 2.28 ug)2016European journal of medicinal chemistry, May-23, Volume: 114Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
AID1291716Lipophilicity, log P of compound2016European journal of medicinal chemistry, May-23, Volume: 114Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
AID266764Membrane permeability, CA(t)/CD(0) in 70% silicon-30% IPM membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID496925Inhibition of mouse carbonic anhydrase 15 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID229377Ratio of kcat/Km determined for catalytic efficiency in sulfonation against AST IV2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID1291715Protective activity against Daboia russellii venom-induced hemorrhage in intradermally dosed Swiss albino mouse at 100 mmol assessed as hemorhagic lesion preincubated with venom for 1 hr followed by administration to mouse measured after 24 hrs relative t2016European journal of medicinal chemistry, May-23, Volume: 114Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
AID288192Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID266771Permeability in human skin2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID1291721Protective activity against Daboia russellii venom-induced hemorrhage in Swiss albino mouse at 100 mmol, iv assessed as hemorhagic lesion by measuring minimal hemolytic dose administered immediately after venom injection measured after 24 hrs (Rvb =5 ug)2016European journal of medicinal chemistry, May-23, Volume: 114Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
AID23676Partition coefficient (logP)1981Journal of medicinal chemistry, Nov, Volume: 24, Issue:11
Acidic epinephrine analogues derived from 1H, 3H-2,1,3-benzothiadiazole 2,2-dioxide and from trifluoromethanesulfonanilide. A new synthesis of 1H,3H-2,1,3-benzothiadiazole 2,2-dioxide.
AID1291717Protective activity against Daboia russellii venom-induced mortality in Swiss albino mouse at 100 mmol, iv by measuring venom LD50 administered immediately after venom injection measured after 24 hrs (Rvb = 2.28ug)2016European journal of medicinal chemistry, May-23, Volume: 114Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
AID1571461Antiproliferative activity against human IN1472 cells after 72 hrs by sulforhodamine B assay2018MedChemComm, Nov-01, Volume: 9, Issue:11
Towards identifying potent new hits for glioblastoma.
AID266768Membrane permeability, CA(t)/CD(0) in 100% silicon membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID1449738Inhibition of Malassezia globosa recombinant beta-carbonic anhydrase preincubated for 15 mins prior to testing measured for 10 to 100 secs by phenol red-based stopped-flow CO2 hydration assay2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Inhibition of Malassezia globosa carbonic anhydrase with phenols.
AID568364Inhibition of human carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.
AID238123Dissociation constant against T4 lysozyme mutant L99A/M102Q2005Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
Decoys for docking.
AID462277Inhibition of human CA7 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1134599CHCl3-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID496916Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID1312214Substrate activity at mushroom tyrosinase assessed as Kcat for monophenolase activity in presence H2O2 by spectrophotometry based Michaelis-Menten plot analysis2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Characterization of the action of tyrosinase on resorcinols.
AID219761Loss of righting reflex (LORR) in tadpoles was determined for anesthetic activity2002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.
AID1331301n-Octanol/water partition coefficient, log P of the compound by HPLC method
AID728447Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102E double mutant expressed in Escherichia coli BL21(DE3) by isothermal titration calorimetry2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
AID636078Cytotoxicity against CHO cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents.
AID502077Inhibition of human carbonic anhydrase 9 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID496924Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID1291719Protective activity against Naja kaouthia venom-induced mortality in Swiss albino mouse at 100 mmol, iv by measuring venom LD50 administered immediately after venom injection measured after 24 hrs (Rvb = 2.82 ug)2016European journal of medicinal chemistry, May-23, Volume: 114Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
AID725602Inhibition of human carbonic anhydrase 2 by stopped flow assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity.
AID1058081Inhibition of human recombinant carbonic anhydrase 9-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
AID501910Inhibition of human carbonic anhydrase 7 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID25611Dissociation constant (pKa)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID501912Inhibition of human carbonic anhydrase 12 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID282836Cytotoxicity against human HL60 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID588193Selectivity ratio of Ki for human recombinant alpha-carbonic anhydrase 1 to Ki for Cryptococcus neoformans recombinant Can2 beta-carbonic anhydrase2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID496923Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID1257050Inhibition of human carbonic anhydrase 1 incubated for 15 mins prior to testing by stopped flow CO2 hydration assay2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives.
AID588190Selectivity ratio of Ki for human recombinant alpha-carbonic anhydrase 1 to Ki for Mycobacterium tuberculosis recombinant Rv3273 beta-carbonic anhydrase2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID26548compound was evaluated for reverse occurs for the rate constant(log K-1) at pH 7.41998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
AID203473Binding constant against bovine serum albumin1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID496919Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID1127992Inhibition of NorA in fluoroquinolone-resistant Staphylococcus aureus 1199B assessed as potentiation of 4 ug/ml of ciprofloxacin MIC at 100 ug/ml after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1127995Toxicity in Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1571460Antiproliferative activity against human U251MG cells after 72 hrs by sulforhodamine B assay2018MedChemComm, Nov-01, Volume: 9, Issue:11
Towards identifying potent new hits for glioblastoma.
AID1134602Hexane-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1312215Substrate activity at mushroom tyrosinase assessed as Kcat/Km ratio for monophenolase activity in presence H2O2 by spectrophotometry based Michaelis-Menten plot analysis2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Characterization of the action of tyrosinase on resorcinols.
AID28956Partition coefficient (logP) (dodecane)2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Rational determination of transfer free energies of small drugs across the water-oil interface.
AID266770Membrane permeability, CA(t)/CD(0) in 100% IPM membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID462276Inhibition of human CA6 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID13312991-octanol/D2O distribution coefficient, log D of the compound at pH 7.4 by 1H NMR spectroscopic analysis
AID725595Inhibition of human CA1 by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
AID72641Direct activation of human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-22002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.
AID1291714Protective activity against Daboia russellii venom-induced hemorrhage in intradermally dosed Swiss albino mouse at 100 mmol assessed as hemorhagic lesion by measuring minimal hemolytic dose preincubated with venom for 1 hr followed by administration to mo2016European journal of medicinal chemistry, May-23, Volume: 114Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
AID266762Effective permeability coefficient in 100% IPM membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID568365Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.
AID728448Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102Q double mutant expressed in Escherichia coli BL21(DE3) by isothermal titration calorimetry2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
AID588191Selectivity ratio of Ki for human recombinant alpha-carbonic anhydrase 1 to Ki for Mycobacterium tuberculosis recombinant Rv1284 beta-carbonic anhydrase2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID729582Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID1571459Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay2018MedChemComm, Nov-01, Volume: 9, Issue:11
Towards identifying potent new hits for glioblastoma.
AID462280Inhibition of mouse CA13 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1257052Inhibition of human carbonic anhydrase 9 incubated for 15 mins prior to testing by stopped flow CO2 hydration assay2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives.
AID282834Activity against caspase-mediated apoptosis in mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID496918Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID1571462Antiproliferative activity against human IN1528 cells after 72 hrs by sulforhodamine B assay2018MedChemComm, Nov-01, Volume: 9, Issue:11
Towards identifying potent new hits for glioblastoma.
AID462271Inhibition of human CA2 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID729576Inhibition of human carbonic anhydrase 6 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID1145386Partition coefficient, log P of the compound by shake-flask technique1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Direct measurement of octanol-water partition coefficients by high-pressure liquid chromatography.
AID462273Inhibition of human CA4 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID26563compound was evaluated for rate constant of transfer (log K1) at pH 7.41998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
AID462281Inhibition of human CA14 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID19254Partition coefficient of compound was measured in heptane/water system1993Journal of medicinal chemistry, Nov-26, Volume: 36, Issue:24
Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations.
AID729572Inhibition of human carbonic anhydrase 13 preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID729577Inhibition of human carbonic anhydrase 5B preincubated for 15 mins by CO2 hydration stopped-flow assay2013Bioorganic & medicinal chemistry, Mar-15, Volume: 21, Issue:6
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
AID636075Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs by lactate dehydrogenase assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Synthesis, biological evaluation and mechanistic studies of totarol amino alcohol derivatives as potential antimalarial agents.
AID1291722Protective activity against Daboia russellii venom-induced hemorrhage in Swiss albino mouse at 100 mmol, iv assessed as hemorhagic lesion administered immediately after venom injection measured after 24 hrs relative to untreated control2016European journal of medicinal chemistry, May-23, Volume: 114Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
AID728450Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102H double mutant expressed in Escherichia coli BL21(DE3) by isothermal titration calorimetry2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
AID168703Inhibition of Rana pipiens muscle activity.1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID501903Inhibition of human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
AID588186Inhibition of human recombinant alpha-carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID282838Cytotoxicity against human CCRF-CEM cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID1145607Octanol-aqueous phase distribution coefficient, log D of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1449741Selectivity ratio of Ki for recombinant human carbonic anhydrase 1 to Ki for recombinant Malassezia globosa beta-carbonic anhydrase2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Inhibition of Malassezia globosa carbonic anhydrase with phenols.
AID331293Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay2008Bioorganic & medicinal chemistry letters, Jun-15, Volume: 18, Issue:12
Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols.
AID101345Toxicity determined using Golden Orfe Fish Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID1145608Drug absorption in anesthetized rat colon at pH 6.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1386829Cytotoxicity in human K562 cells assessed as reduction in cell viability incubated for 72 hrs by cell-QB reagent based assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Phosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent Vγ9 Vδ2 T Cell Stimulation.
AID588192Selectivity ratio of Ki for human recombinant alpha-carbonic anhydrase 1 to Ki for Candida albicans recombinant Nce103 beta-carbonic anhydrase2011Journal of medicinal chemistry, Mar-24, Volume: 54, Issue:6
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
AID15880Calculated partition coefficient (clogP)2002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.
AID1803139Esterase Activity Assay from Article 10.3109/14756366.2011.637202: \\Simple methanesulfonates are hydrolyzed by the sulfatase carbonic anhydrase activity.\\2012Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 27, Issue:6
Simple methanesulfonates are hydrolyzed by the sulfatase carbonic anhydrase activity.
AID1798641CA Inhibition Assay from Article 10.1016/j.bmc.2008.06.013: \\Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid.\\2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid.
AID1803217Esterase Activity Assay from Article 10.3109/14756366.2011.651464: \\Analysis of saponins and phenolic compounds as inhibitors of a-carbonic anhydrase isoenzymes.\\2013Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 28, Issue:2
Analysis of saponins and phenolic compounds as inhibitors of α-carbonic anhydrase isoenzymes.
AID1803140Esterase Activity Assay from Article 10.3109/14756366.2011.643303: \\Carbonic anhydrase inhibitors: in vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.\\2013Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 28, Issue:2
Carbonic anhydrase inhibitors: in vitro inhibition of α isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.
AID1803136CA Activity Assay from Article 10.3109/14756366.2011.621122: \\Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds.\\2012Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 27, Issue:6
Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2002Journal of molecular biology, Sep-13, Volume: 322, Issue:2
A model binding site for testing scoring functions in molecular docking.
AID1811Experimentally measured binding affinity data derived from PDB2002Journal of molecular biology, Sep-13, Volume: 322, Issue:2
A model binding site for testing scoring functions in molecular docking.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2009The Journal of biological chemistry, Sep-04, Volume: 284, Issue:36
A unitary anesthetic binding site at high resolution.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1998Journal of molecular biology, Nov-27, Volume: 284, Issue:2
Ligand-induced conformational change in penicillin acylase.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6,258)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901015 (16.22)18.7374
1990's685 (10.95)18.2507
2000's1730 (27.64)29.6817
2010's1949 (31.14)24.3611
2020's879 (14.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 100.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index100.42 (24.57)
Research Supply Index8.81 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index193.52 (26.88)
Search Engine Supply Index2.06 (0.95)

This Compound (100.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials101 (1.54%)5.53%
Reviews214 (3.26%)6.00%
Case Studies151 (2.30%)4.05%
Observational2 (0.03%)0.25%
Other6,103 (92.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (27)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Bioequivalence Study of Calcium Hydroxybenzene Sulphonate Dispersible Tablets and Calcium Hydroxybenzene Sulfonate Tablets (Doxium®) Under Fed Conditions in Chinese Healthy Volunteers [NCT05794919]56 participants (Anticipated)Interventional2023-03-20Recruiting
Comparative Effect Of Different Oils For Frying On The Endothelial Function, The Oxidative Stress And The Postprandial Inflammatory Response [NCT00837317]26 participants (Actual)Interventional2009-01-31Completed
Auramine Phenol Staining Technique for Revealing Different Coccidian Parasites [NCT05724381]100 participants (Anticipated)Observational2023-03-31Not yet recruiting
Previously Operated Recurrent Pilonidal Sinus Treated With Crystallized Phenol: Twenty Years Experience [NCT04423510]227 participants (Actual)Observational1995-03-01Completed
Phase II Grape Seed Extract as Anti-Oligomerization Agent in Alzheimer's Disease [NCT02033941]Phase 220 participants (Anticipated)Interventional2018-07-03Suspended(stopped due to Study has been suspended for the duration of the pandemic. We hope to re-start enrollment later this year)
The Effect of Adding Phenol With Fluoroscopy Guided Radiofrequency Ablation of T2-T3 Versus Thoracoscopic Sympathectomy in Palmar Hyperhidrosis. [NCT03506828]82 participants (Anticipated)Interventional2018-02-01Enrolling by invitation
Prospective Study of the Efficacy of Ultrasound-guided Genicular Nerve Block With Phenol for the Treatment of Chronic Pain Due to Knee Osteoarthritis [NCT03601533]15 participants (Anticipated)Interventional2018-06-05Recruiting
Patients With Knee Pain Caused by Osteoarthritis: Comparison of Conservative Medical Management With RadioFrequency Ablation or Chemical Neurolysis of the Genicular Nerves With Phenol [NCT06094660]192 participants (Anticipated)Interventional2023-11-27Recruiting
Randomized Prospective Comparison of Crystallized Phenol and Platelet Rich Plasma Applications in Treatment of Pilonidal Sinus Disease [NCT03070028]200 participants (Actual)Interventional2017-01-01Completed
Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection [NCT04794842]Early Phase 180 participants (Actual)Interventional2021-08-01Active, not recruiting
Phenol Neurolysis of Genicular Nerves for Chronic Knee Pain Following Total Knee Arthroplasty: a Pilot Prospective, Randomized, Crossover Trial [NCT03973177]Phase 40 participants (Actual)Interventional2019-05-24Withdrawn(stopped due to Covid restrictions on recruitment)
Genetics of Environmental Asthma: Differential Gene Expression in the Lung and Peripheral Blood After Inhaled Allergen Challenge [NCT00671593]Phase 140 participants (Actual)Interventional2006-10-31Terminated(stopped due to funding terminated)
Sustained Effects of Cranberry (Poly)Phenol Consumption on Vascular Function in Healthy Individuals [NCT02764749]40 participants (Actual)Interventional2016-06-30Completed
Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests [NCT01989897]Phase 1/Phase 20 participants (Actual)Interventional2013-03-31Withdrawn(stopped due to Funding for the trial was lost so study was ended. No participants were enrolled.)
Histological Evaluation of Peeling Induced Skin Changes of Different Peeling Agents in Surgically Subcutaneous Undermined Skin Flaps in Facelift Patients [NCT02848209]9 participants (Actual)Interventional2016-07-31Completed
Efficacy of Genicular Artery Embolization Compared to Sensory Deinnervation for the Treatment of Symptomatic Knee Osteoarthritis: a Randomized Controlled Trial [NCT06166628]150 participants (Anticipated)Interventional2023-12-01Recruiting
Phase II Study to Assess the Efficacy and Safety of Subcutaneous AGX-201 for Migraine Prophylaxis [NCT02021474]Phase 2130 participants (Anticipated)Interventional2022-10-31Not yet recruiting
Impact of the Consumption of (Poly)Phenolic Rich Products on Cardiometabolic Risk Markers in Postmenopausal Women [NCT05255367]26 participants (Actual)Interventional2022-03-01Completed
Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs [NCT01468415]Phase 160 participants (Anticipated)Interventional2011-06-30Recruiting
Phenol Neurolysis of Genicular Nerves for Osteoarthritic Knee Pain [NCT04989660]Phase 430 participants (Anticipated)Interventional2021-11-01Recruiting
Identification of Aggregate Metabolic Phenotypes for the Main Dietary (Poly)Phenols and Assessment of the Factors Associated With Their Formation: Development of an Oral (Poly)Phenol Challenge Test (OPCT) [NCT05414084]300 participants (Anticipated)Interventional2022-05-31Recruiting
Comparison of Phenol and Silver Nitrate Application in the Sacrococcygeal Pilonidal Sinus: A Prospective Randomized Controlled Study [NCT04560049]Phase 4140 participants (Anticipated)Interventional2020-06-03Recruiting
2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis [NCT05274243]Phase 232 participants (Anticipated)Interventional2022-08-09Recruiting
Crystallized Phenol Application Versus Transposition Flaps for Treatment of Sacrococcygeal Pilonidal Disease: A Prospective Randomized Study [NCT01792557]200 participants (Anticipated)Interventional2013-03-31Active, not recruiting
Factors Affecting Outcomes of Crystallized Phenol Application in the Treatment of Pilonidal Sinus Disease [NCT04681443]Phase 4100 participants (Actual)Interventional2018-01-01Completed
Short Term Effect of Ultrasound and Peripheral Nerve Stimulator Guided Femoral Nerve Block With Phenol on Outcomes in People With Traumatic Spinal Cord Injury [NCT03468439]14 participants (Actual)Interventional2014-01-31Completed
Randomized, Double-blinded, Comparison Between Ultrasound-Guided Genicular Nerve Phenol Neurolysis and Intra-articular Steroid Injections [NCT06000709]Phase 440 participants (Anticipated)Interventional2023-10-20Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]